category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology
GO:0005575,1.9532807108885043e-68,1,431,19168,cellular_component,CC
GO:0008150,3.285339194761242e-65,1,413,18203,biological_process,BP
GO:0003674,2.9123041141601173e-62,1,404,17424,molecular_function,MF
GO:0050896,3.2354656711151584e-59,1,275,9017,response to stimulus,BP
GO:0005576,8.069592332073539e-56,1,179,4406,extracellular region,CC
GO:0044464,2.2932231102154273e-54,1,383,17038,cell part,CC
GO:0009987,2.7262710753443956e-54,1,373,16683,cellular process,BP
GO:0005623,6.052410421137599e-54,1,383,17107,cell,CC
GO:0005488,4.168973342234781e-53,1,355,15078,binding,MF
GO:0065007,1.788425412428386e-52,1,316,12580,biological regulation,BP
GO:0032501,4.740162781234215e-52,1,241,7718,multicellular organismal process,BP
GO:0050789,5.295017764635274e-50,1,301,11899,regulation of biological process,BP
GO:0023052,4.595658457555656e-47,1,211,6485,signaling,BP
GO:0002376,8.062626863177627e-47,1,137,2919,immune system process,BP
GO:0007166,4.3851073221013995e-45,1,136,2947,cell surface receptor signaling pathway,BP
GO:0007154,4.4907097455430813e-45,1,208,6512,cell communication,BP
GO:0006952,4.667529752716235e-44,1,101,1677,defense response,BP
GO:0051716,2.73059571491318e-43,1,221,7470,cellular response to stimulus,BP
GO:0044421,4.948669841534566e-43,1,143,3604,extracellular region part,CC
GO:0007165,2.3522366977366164e-42,1,194,6021,signal transduction,BP
GO:0006955,4.564069841967187e-42,1,108,2009,immune response,BP
GO:0050794,1.3147477687033962e-41,1,272,10851,regulation of cellular process,BP
GO:0010033,1.3244339622525395e-41,1,138,3297,response to organic substance,BP
GO:0006950,2.0764016785275543e-40,1,150,3981,response to stress,BP
GO:0009605,1.1813007735722094e-39,1,115,2416,response to external stimulus,BP
GO:0005615,1.8832410758121975e-39,1,133,3403,extracellular space,CC
GO:0048518,9.834957781556834e-39,1,189,6135,positive regulation of biological process,BP
GO:0071310,1.9548051010735622e-38,1,120,2704,cellular response to organic substance,BP
GO:0005737,2.0795107615230872e-38,1,276,11561,cytoplasm,CC
GO:0042221,2.5473450260772606e-38,1,163,4765,response to chemical,BP
GO:0070887,5.070061102760798e-38,1,132,3278,cellular response to chemical stimulus,BP
GO:0016020,9.555503242010068e-38,1,240,9170,membrane,CC
GO:0034097,2.4629363089467243e-37,1,80,1208,response to cytokine,BP
GO:0005515,3.1894470584582686e-37,1,276,11717,protein binding,MF
GO:0048856,1.0363285665120292e-36,1,183,5987,anatomical structure development,BP
GO:0044424,6.732418602710245e-36,1,314,14885,intracellular part,CC
GO:0005622,7.68640727287026e-36,1,314,14895,intracellular,CC
GO:0044425,1.0280392173738641e-35,1,196,6705,membrane part,CC
GO:0007275,1.1837454754335698e-35,1,172,5489,multicellular organism development,BP
GO:0048731,1.827373872237379e-35,1,161,4917,system development,BP
GO:0032502,5.204596237581481e-35,1,187,6407,developmental process,BP
GO:0045087,6.957414629826385e-35,1,68,923,innate immune response,BP
GO:0071944,1.5692993198196294e-34,1,172,5456,cell periphery,CC
GO:0051239,3.100396349666615e-34,1,125,3260,regulation of multicellular organismal process,BP
GO:0031224,3.2249595859080153e-34,1,171,5426,intrinsic component of membrane,CC
GO:0005886,4.713752425862904e-34,1,169,5337,plasma membrane,CC
GO:0071345,8.80538564736098e-34,1,73,1114,cellular response to cytokine stimulus,BP
GO:0048583,1.6525218426312287e-33,1,144,4231,regulation of response to stimulus,BP
GO:0044459,4.401633914265685e-33,1,117,2812,plasma membrane part,CC
GO:0019221,5.244730266259245e-33,1,62,795,cytokine-mediated signaling pathway,BP
GO:0051179,3.474503659711768e-32,1,184,6615,localization,BP
GO:0016021,1.3784152499094736e-31,1,163,5261,integral component of membrane,CC
GO:0005102,3.872375913308352e-31,1,82,1547,signaling receptor binding,MF
GO:0048519,2.67412712033904e-30,1,162,5843,negative regulation of biological process,BP
GO:0051704,4.3852900094947256e-30,1,104,2562,multi-organism process,BP
GO:0051707,6.473538014198353e-30,1,63,945,response to other organism,BP
GO:0043207,7.258383160454074e-30,1,63,947,response to external biotic stimulus,BP
GO:0048869,2.7940308701997673e-29,1,141,4427,cellular developmental process,BP
GO:0030154,5.115065636064974e-29,1,137,4234,cell differentiation,BP
GO:0009607,5.235945068470659e-29,1,63,979,response to biotic stimulus,BP
GO:0043227,1.1471149675850998e-28,1,268,12857,membrane-bounded organelle,CC
GO:0048522,9.43060604019589e-28,1,155,5417,positive regulation of cellular process,BP
GO:0051234,1.0464662577259512e-27,1,151,5199,establishment of localization,BP
GO:0044444,2.0196402587754603e-27,1,223,9707,cytoplasmic part,CC
GO:0006810,2.423768983217523e-27,1,148,5072,transport,BP
GO:0002682,5.148289636681773e-27,1,76,1546,regulation of immune system process,BP
GO:0043226,5.580639870383454e-27,1,279,13953,organelle,CC
GO:0048584,1.1232460673358547e-26,1,95,2388,positive regulation of response to stimulus,BP
GO:1901564,2.2321180434403246e-26,1,176,6915,organonitrogen compound metabolic process,BP
GO:0002252,3.342605709814396e-26,1,65,1162,immune effector process,BP
GO:0065008,6.952892023171585e-26,1,127,4054,regulation of biological quality,BP
GO:0023051,9.104942268184879e-26,1,118,3596,regulation of signaling,BP
GO:0043167,6.909053169204493e-25,1,164,6182,ion binding,MF
GO:0048523,1.6068943147432595e-24,1,138,4892,negative regulation of cellular process,BP
GO:0051240,2.329565062608916e-24,1,78,1809,positive regulation of multicellular organismal process,BP
GO:0031982,3.779410833247922e-24,1,119,3851,vesicle,CC
GO:0010646,3.8828389608783195e-24,1,114,3548,regulation of cell communication,BP
GO:0044238,1.2181168973643167e-23,1,229,11076,primary metabolic process,BP
GO:0071704,1.4240847309707897e-23,1,236,11860,organic substance metabolic process,BP
GO:0008152,4.672915729252393e-23,1,241,12321,metabolic process,BP
GO:0051241,6.442312144792601e-23,1,63,1317,negative regulation of multicellular organismal process,BP
GO:0032879,8.565793962828876e-23,1,97,2853,regulation of localization,BP
GO:0009653,1.9133108047282013e-22,1,95,2737,anatomical structure morphogenesis,BP
GO:0006807,4.0330380911430054e-22,1,218,10602,nitrogen compound metabolic process,BP
GO:0048513,5.312158234006205e-22,1,111,3584,animal organ development,BP
GO:0042127,5.341125496610194e-22,1,71,1698,regulation of cell proliferation,BP
GO:0009966,1.0335426122698332e-21,1,102,3176,regulation of signal transduction,BP
GO:0012505,2.0423991788928317e-21,1,125,4437,endomembrane system,CC
GO:0043229,2.7323867468994063e-21,1,252,13133,intracellular organelle,CC
GO:0034341,2.747436286878822e-21,1,27,195,response to interferon-gamma,BP
GO:0002684,2.861541096140805e-21,1,56,1073,positive regulation of immune system process,BP
GO:0019538,3.146285858146783e-21,1,147,5864,protein metabolic process,BP
GO:0008283,3.223320253262754e-21,1,77,2023,cell proliferation,BP
GO:0046903,4.135882228100416e-21,1,70,1658,secretion,BP
GO:0042592,7.958704403048868e-21,1,75,1917,homeostatic process,BP
GO:0002697,1.0476231875167475e-20,1,35,397,regulation of immune effector process,BP
GO:0051049,1.1056156352841595e-20,1,74,1879,regulation of transport,BP
GO:0035556,1.1155220893711845e-20,1,96,2958,intracellular signal transduction,BP
GO:0050793,1.2800142798325302e-20,1,90,2696,regulation of developmental process,BP
GO:0050776,1.7636067877359326e-20,1,53,1001,regulation of immune response,BP
GO:0009986,7.377720619422144e-20,1,48,817,cell surface,CC
GO:0060337,8.416165339950796e-20,1,20,95,type I interferon signaling pathway,BP
GO:0071357,8.416165339950796e-20,1,20,95,cellular response to type I interferon,BP
GO:0044237,1.6150533811038607e-19,1,219,11196,cellular metabolic process,BP
GO:0034340,2.0866658684106748e-19,1,20,99,response to type I interferon,BP
GO:0065009,2.185889378670119e-19,1,94,2985,regulation of molecular function,BP
GO:0010647,3.392102547468874e-19,1,71,1847,positive regulation of cell communication,BP
GO:0023056,4.0350122769494657e-19,1,71,1853,positive regulation of signaling,BP
GO:0001816,4.263341671261617e-19,1,45,788,cytokine production,BP
GO:0031347,6.54743177052561e-19,1,46,841,regulation of defense response,BP
GO:0071346,7.151924373760998e-19,1,24,176,cellular response to interferon-gamma,BP
GO:0032940,1.0234259014265726e-18,1,63,1522,secretion by cell,BP
GO:0003008,1.181432444641645e-18,1,78,2194,system process,BP
GO:0031226,1.2432710049312817e-18,1,69,1707,intrinsic component of plasma membrane,CC
GO:0001525,1.4516954174536558e-18,1,37,587,angiogenesis,BP
GO:0006954,1.4990026443166455e-18,1,44,786,inflammatory response,BP
GO:0016043,2.0189290666527586e-18,1,150,6431,cellular component organization,BP
GO:0009615,2.1300002164440054e-18,1,30,326,response to virus,BP
GO:0022610,2.3899293433824488e-18,1,61,1426,biological adhesion,BP
GO:0009967,2.50744465755265e-18,1,66,1688,positive regulation of signal transduction,BP
GO:0048646,3.819077081648565e-18,1,53,1173,anatomical structure formation involved in morphogenesis,BP
GO:0098542,3.876567494284923e-18,1,35,499,defense response to other organism,BP
GO:0098772,4.581114295597546e-18,1,68,1808,molecular function regulator,MF
GO:0043168,5.902615484155759e-18,1,88,2760,anion binding,MF
GO:0030545,6.059950713151364e-18,1,36,528,receptor regulator activity,MF
GO:0005887,6.670795410215822e-18,1,66,1628,integral component of plasma membrane,CC
GO:0035295,6.811998263165084e-18,1,51,1111,tube development,BP
GO:0007155,7.731602159327257e-18,1,60,1419,cell adhesion,BP
GO:0048514,8.42814176532317e-18,1,39,681,blood vessel morphogenesis,BP
GO:0031410,8.774258615516374e-18,1,78,2312,cytoplasmic vesicle,CC
GO:0043170,8.883926230800981e-18,1,197,10282,macromolecule metabolic process,BP
GO:2000026,9.099837499212485e-18,1,74,2158,regulation of multicellular organismal development,BP
GO:0071840,9.364978983163024e-18,1,151,6615,cellular component organization or biogenesis,BP
GO:0097708,9.366100064354306e-18,1,78,2315,intracellular vesicle,CC
GO:1902533,1.1983177299428981e-17,1,51,1082,positive regulation of intracellular signal transduction,BP
GO:0001944,1.2250662509936202e-17,1,42,793,vasculature development,BP
GO:0001817,1.3806057094806549e-17,1,41,717,regulation of cytokine production,BP
GO:0001568,1.6246099710634596e-17,1,41,761,blood vessel development,BP
GO:0072358,1.94075653938614e-17,1,42,802,cardiovascular system development,BP
GO:0009617,3.240921088752395e-17,1,38,631,response to bacterium,BP
GO:0001775,4.186429306266121e-17,1,57,1370,cell activation,BP
GO:0002443,4.712863620285661e-17,1,42,770,leukocyte mediated immunity,BP
GO:0097367,7.620403687742877e-17,1,75,2206,carbohydrate derivative binding,MF
GO:0051607,8.578812518842694e-17,1,25,239,defense response to virus,BP
GO:0006811,1.0721707489860181e-16,1,64,1691,ion transport,BP
GO:0044267,1.0750593806055416e-16,1,126,5260,cellular protein metabolic process,BP
GO:1901700,1.236047109139618e-16,1,62,1638,response to oxygen-containing compound,BP
GO:0048018,1.4272110013680806e-16,1,33,484,receptor ligand activity,MF
GO:0032101,1.845237258780657e-16,1,43,852,regulation of response to external stimulus,BP
GO:0080134,1.9490369155040203e-16,1,60,1584,regulation of response to stress,BP
GO:0048585,2.1431075913734373e-16,1,62,1695,negative regulation of response to stimulus,BP
GO:0060333,3.074385894544017e-16,1,17,88,interferon-gamma-mediated signaling pathway,BP
GO:0009893,4.066406797472655e-16,1,99,3630,positive regulation of metabolic process,BP
GO:0043231,5.74980257079137e-16,1,211,11360,intracellular membrane-bounded organelle,CC
GO:0008219,6.445877450569711e-16,1,73,2263,cell death,BP
GO:0072359,8.056557491292275e-16,1,49,1173,circulatory system development,BP
GO:0043169,9.364574116944154e-16,1,110,4255,cation binding,MF
GO:0035239,1.0441940795087994e-15,1,43,921,tube morphogenesis,BP
GO:0002703,1.9684219142933307e-15,1,22,201,regulation of leukocyte mediated immunity,BP
GO:1902531,2.697996029653467e-15,1,66,1967,regulation of intracellular signal transduction,BP
GO:0098590,3.0942161070033347e-15,1,51,1203,plasma membrane region,CC
GO:0012501,3.604559613415082e-15,1,69,2131,programmed cell death,BP
GO:0046872,3.746296113091527e-15,1,107,4166,metal ion binding,MF
GO:0050778,3.7585491421871094e-15,1,40,790,positive regulation of immune response,BP
GO:0044260,4.121548242564555e-15,1,169,8312,cellular macromolecule metabolic process,BP
GO:0019222,5.857768527398003e-15,1,148,7192,regulation of metabolic process,BP
GO:0048878,8.114665888167948e-15,1,49,1188,chemical homeostasis,BP
GO:0080090,1.0195070266308717e-14,1,136,6145,regulation of primary metabolic process,BP
GO:1901342,1.0811825767359983e-14,1,27,424,regulation of vasculature development,BP
GO:0008284,1.1009687194812143e-14,1,43,948,positive regulation of cell proliferation,BP
GO:0009888,1.5807014236586064e-14,1,67,2064,tissue development,BP
GO:0031325,1.951993528562715e-14,1,90,3324,positive regulation of cellular metabolic process,BP
GO:0006464,2.7440150486805562e-14,1,103,4153,cellular protein modification process,BP
GO:0036211,2.7440150486805562e-14,1,103,4153,protein modification process,BP
GO:0036094,3.0890282133766886e-14,1,75,2490,small molecule binding,MF
GO:0010562,3.837812276110028e-14,1,47,1139,positive regulation of phosphorus metabolic process,BP
GO:0045937,3.837812276110028e-14,1,47,1139,positive regulation of phosphate metabolic process,BP
GO:0022603,4.685047978372429e-14,1,46,1157,regulation of anatomical structure morphogenesis,BP
GO:0055085,5.104581142836824e-14,1,57,1592,transmembrane transport,BP
GO:0006796,5.151528624140705e-14,1,88,3310,phosphate-containing compound metabolic process,BP
GO:0055065,5.754183856541118e-14,1,35,653,metal ion homeostasis,BP
GO:0045765,5.831813192210207e-14,1,25,384,regulation of angiogenesis,BP
GO:0055080,5.842542942552257e-14,1,37,730,cation homeostasis,BP
GO:0042802,6.558478109643597e-14,1,59,1729,identical protein binding,MF
GO:0043230,7.335858728252952e-14,1,66,2158,extracellular organelle,CC
GO:0007267,7.979382856768363e-14,1,58,1650,cell-cell signaling,BP
GO:0006793,8.029339314415621e-14,1,88,3337,phosphorus metabolic process,BP
GO:0045321,8.181440237776625e-14,1,48,1214,leukocyte activation,BP
GO:0051246,8.553570090165115e-14,1,79,2868,regulation of protein metabolic process,BP
GO:0002699,8.78049576325559e-14,1,21,216,positive regulation of immune effector process,BP
GO:0098771,9.24975615922421e-14,1,37,741,inorganic ion homeostasis,BP
GO:0043412,9.85319503165052e-14,1,105,4365,macromolecule modification,BP
GO:0031323,9.960854630636063e-14,1,135,6279,regulation of cellular metabolic process,BP
GO:0048468,1.1728125705746252e-13,1,68,2180,cell development,BP
GO:0001819,1.3646422827745556e-13,1,29,462,positive regulation of cytokine production,BP
GO:0051171,1.3900182502031516e-13,1,130,5973,regulation of nitrogen compound metabolic process,BP
GO:0040011,1.6183873813535564e-13,1,61,1917,locomotion,BP
GO:0043900,1.626036962632003e-13,1,27,404,regulation of multi-organism process,BP
GO:1903561,1.999045016471653e-13,1,65,2153,extracellular vesicle,CC
GO:0034220,2.339978680622063e-13,1,47,1177,ion transmembrane transport,BP
GO:0050790,2.710345278039866e-13,1,69,2330,regulation of catalytic activity,BP
GO:0050801,2.8528969189826175e-13,1,38,811,ion homeostasis,BP
GO:0030001,2.9010335871745343e-13,1,40,882,metal ion transport,BP
GO:0044433,3.2443649737767583e-13,1,53,1501,cytoplasmic vesicle part,CC
GO:0019220,3.576790308075852e-13,1,59,1812,regulation of phosphate metabolic process,BP
GO:0051174,3.75385635745724e-13,1,59,1814,regulation of phosphorus metabolic process,BP
GO:0070062,3.794742600753525e-13,1,64,2130,extracellular exosome,CC
GO:0006812,4.151461075789569e-13,1,46,1157,cation transport,BP
GO:0002250,4.41198132653053e-13,1,27,412,adaptive immune response,BP
GO:0050877,4.4553883723578963e-13,1,52,1417,nervous system process,BP
GO:0008285,4.90590537060957e-13,1,35,762,negative regulation of cell proliferation,BP
GO:0010604,5.306080291347479e-13,1,87,3358,positive regulation of macromolecule metabolic process,BP
GO:0016477,6.258102149589949e-13,1,52,1533,cell migration,BP
GO:0009897,6.517981945036923e-13,1,24,316,external side of plasma membrane,CC
GO:0060255,7.031409981773958e-13,1,134,6675,regulation of macromolecule metabolic process,BP
GO:0001934,7.500688583681463e-13,1,42,1015,positive regulation of protein phosphorylation,BP
GO:0098660,8.288969225770475e-13,1,38,833,inorganic ion transmembrane transport,BP
GO:0042327,9.409267247126457e-13,1,43,1066,positive regulation of phosphorylation,BP
GO:0007399,9.738172306753417e-13,1,70,2377,nervous system development,BP
GO:0016032,1.0479964312043537e-12,1,37,829,viral process,BP
GO:0031399,1.1137094668530014e-12,1,59,1864,regulation of protein modification process,BP
GO:0032268,1.1562899887054959e-12,1,73,2671,regulation of cellular protein metabolic process,BP
GO:0001932,1.296819224806642e-12,1,51,1463,regulation of protein phosphorylation,BP
GO:0010941,1.3129247141616297e-12,1,56,1736,regulation of cell death,BP
GO:0002456,1.3720960515696777e-12,1,15,106,T cell mediated immunity,BP
GO:0006915,1.399045022206748e-12,1,61,1987,apoptotic process,BP
GO:0045595,1.5701881700041635e-12,1,59,1876,regulation of cell differentiation,BP
GO:0051093,1.6531290029064952e-12,1,41,1045,negative regulation of developmental process,BP
GO:0098655,1.6679761783798024e-12,1,38,852,cation transmembrane transport,BP
GO:0051173,1.879999564492064e-12,1,83,3194,positive regulation of nitrogen compound metabolic process,BP
GO:0031401,2.1667645249539313e-12,1,46,1234,positive regulation of protein modification process,BP
GO:0033993,3.14771539873927e-12,1,39,924,response to lipid,BP
GO:0002705,3.413660578589299e-12,1,16,133,positive regulation of leukocyte mediated immunity,BP
GO:0051050,3.57607254180952e-12,1,40,980,positive regulation of transport,BP
GO:0042325,3.9530619849818365e-12,1,53,1611,regulation of phosphorylation,BP
GO:0001906,4.283765192711466e-12,1,17,168,cell killing,BP
GO:0071702,4.635355790076415e-12,1,74,2788,organic substance transport,BP
GO:0006468,4.667137351956078e-12,1,60,1979,protein phosphorylation,BP
GO:0044419,5.35153584853208e-12,1,38,929,interspecies interaction between organisms,BP
GO:0044403,5.695989651649458e-12,1,37,880,symbiont process,BP
GO:0046983,6.163718132921477e-12,1,47,1330,protein dimerization activity,MF
GO:0044093,7.076854971966163e-12,1,56,1773,positive regulation of molecular function,BP
GO:0003824,7.2625852107552605e-12,1,121,5689,catalytic activity,MF
GO:0034612,7.84943617881766e-12,1,22,313,response to tumor necrosis factor,BP
GO:0006508,7.854927602898486e-12,1,56,1806,proteolysis,BP
GO:0048870,8.172700948663361e-12,1,53,1691,cell motility,BP
GO:0051674,8.172700948663361e-12,1,53,1691,localization of cell,BP
GO:0043067,8.707042701057186e-12,1,52,1614,regulation of programmed cell death,BP
GO:0010648,9.867306592013443e-12,1,48,1423,negative regulation of cell communication,BP
GO:0002449,9.938252964532778e-12,1,20,248,lymphocyte mediated immunity,BP
GO:1903900,1.0540917138206792e-11,1,16,148,regulation of viral life cycle,BP
GO:0023057,1.0770924438688487e-11,1,48,1427,negative regulation of signaling,BP
GO:0051094,1.2192040367014222e-11,1,48,1418,positive regulation of developmental process,BP
GO:0051247,1.2454571124484081e-11,1,54,1711,positive regulation of protein metabolic process,BP
GO:0015318,1.2653692743262971e-11,1,36,811,inorganic molecular entity transmembrane transporter activity,MF
GO:0032270,1.3418069698621593e-11,1,52,1609,positive regulation of cellular protein metabolic process,BP
GO:0048871,1.4239822279175531e-11,1,27,481,multicellular organismal homeostasis,BP
GO:0098552,1.4568184424104282e-11,1,28,509,side of membrane,CC
GO:0042981,1.7581172063986295e-11,1,51,1588,regulation of apoptotic process,BP
GO:0051128,1.8262784150883904e-11,1,68,2505,regulation of cellular component organization,BP
GO:0002460,2.0863128681383527e-11,1,20,258,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP
GO:0050792,2.3193023090538026e-11,1,18,207,regulation of viral process,BP
GO:0015075,2.5674091003981685e-11,1,37,875,ion transmembrane transporter activity,MF
GO:0022890,2.7685478743421422e-11,1,30,590,inorganic cation transmembrane transporter activity,MF
GO:0002526,3.3587052580688533e-11,1,16,160,acute inflammatory response,BP
GO:0046873,3.563712100928452e-11,1,26,438,metal ion transmembrane transporter activity,MF
GO:0009719,4.587315469751433e-11,1,52,1662,response to endogenous stimulus,BP
GO:0030097,5.3185818009319445e-11,1,36,886,hemopoiesis,BP
GO:0016310,5.697961203973937e-11,1,65,2407,phosphorylation,BP
GO:0098662,6.026216496079814e-11,1,33,749,inorganic cation transmembrane transport,BP
GO:0005215,6.044948175423737e-11,1,42,1134,transporter activity,MF
GO:0042612,6.184859285600421e-11,1,6,8,MHC class I protein complex,CC
GO:0002480,6.228730184589358e-11,1,6,8,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",BP
GO:0002428,6.26442151802129e-11,1,6,8,antigen processing and presentation of peptide antigen via MHC class Ib,BP
GO:0030335,6.357404232610036e-11,1,27,546,positive regulation of cell migration,BP
GO:0002520,6.373914790127078e-11,1,38,980,immune system development,BP
GO:0022857,6.424374611353199e-11,1,40,1039,transmembrane transporter activity,MF
GO:0050673,6.525382510931088e-11,1,24,435,epithelial cell proliferation,BP
GO:0043903,6.528896263068904e-11,1,18,221,"regulation of symbiosis, encompassing mutualism through parasitism",BP
GO:0043901,6.975510760963647e-11,1,16,170,negative regulation of multi-organism process,BP
GO:0048525,7.241072214089053e-11,1,13,99,negative regulation of viral process,BP
GO:0009968,7.773411146283181e-11,1,44,1316,negative regulation of signal transduction,BP
GO:0051046,7.874085490477096e-11,1,34,811,regulation of secretion,BP
GO:0001910,8.397814672361441e-11,1,12,77,regulation of leukocyte mediated cytotoxicity,BP
GO:0046914,8.501182148926857e-11,1,40,1075,transition metal ion binding,MF
GO:0002237,8.771593796683369e-11,1,22,344,response to molecule of bacterial origin,BP
GO:0030659,9.35660707550131e-11,1,33,769,cytoplasmic vesicle membrane,CC
GO:0071356,9.484527781009917e-11,1,20,291,cellular response to tumor necrosis factor,BP
GO:0031341,9.759344992543076e-11,1,13,97,regulation of cell killing,BP
GO:0009628,1.1055551647787885e-10,1,43,1234,response to abiotic stimulus,BP
GO:0033036,1.119685771015672e-10,1,76,3113,macromolecule localization,BP
GO:0040017,1.2227817339855812e-10,1,28,599,positive regulation of locomotion,BP
GO:0030003,1.367483191606943e-10,1,30,652,cellular cation homeostasis,BP
GO:0045596,1.3681383826939434e-10,1,32,754,negative regulation of cell differentiation,BP
GO:0031012,1.453360603028096e-10,1,27,526,extracellular matrix,CC
GO:2000147,1.658412376029689e-10,1,27,569,positive regulation of cell motility,BP
GO:0019058,1.6762068676855396e-10,1,21,327,viral life cycle,BP
GO:0006928,1.7407540541617978e-10,1,59,2154,movement of cell or subcellular component,BP
GO:0019725,1.7698633888280494e-10,1,37,972,cellular homeostasis,BP
GO:0050878,1.7781172077332634e-10,1,26,499,regulation of body fluid levels,BP
GO:0008324,1.8265186952758833e-10,1,30,640,cation transmembrane transporter activity,MF
GO:0012506,1.8351940457566073e-10,1,33,790,vesicle membrane,CC
GO:0006875,1.8485089011115953e-10,1,28,579,cellular metal ion homeostasis,BP
GO:0040012,1.8627007922611462e-10,1,38,1086,regulation of locomotion,BP
GO:1904018,1.8867209824793466e-10,1,17,231,positive regulation of vasculature development,BP
GO:0048534,1.9113560467229882e-10,1,36,928,hematopoietic or lymphoid organ development,BP
GO:0002706,1.9648325273596678e-10,0.9999999999831328,15,148,regulation of lymphocyte mediated immunity,BP
GO:0030334,2.002954319359344e-10,1,35,953,regulation of cell migration,BP
GO:0050727,2.073532458444916e-10,1,23,424,regulation of inflammatory response,BP
GO:0009306,2.2113234544183198e-10,1,28,592,protein secretion,BP
GO:0006873,2.21686809855411e-10,1,30,665,cellular ion homeostasis,BP
GO:0002708,2.335068411577532e-10,0.999999999983972,13,104,positive regulation of lymphocyte mediated immunity,BP
GO:1901701,2.3394458107101966e-10,1,40,1136,cellular response to oxygen-containing compound,BP
GO:0050663,2.39053252572886e-10,1,18,239,cytokine secretion,BP
GO:0052547,2.4253291112004285e-10,1,24,451,regulation of peptidase activity,BP
GO:0044092,2.448248573863187e-10,1,40,1158,negative regulation of molecular function,BP
GO:0009611,2.5932298035909526e-10,1,30,677,response to wounding,BP
GO:0032496,2.6999486093419163e-10,1,21,331,response to lipopolysaccharide,BP
GO:0045766,2.741264707451172e-10,1,16,204,positive regulation of angiogenesis,BP
GO:0001909,2.8252698881049984e-10,0.9999999999802899,13,106,leukocyte mediated cytotoxicity,BP
GO:0007186,2.907446213403039e-10,1,45,1348,G protein-coupled receptor signaling pathway,BP
GO:2000145,3.0517853892304014e-10,1,36,1014,regulation of cell motility,BP
GO:0051272,3.05470855794753e-10,1,27,586,positive regulation of cellular component movement,BP
GO:0055082,3.4725090527154945e-10,1,33,812,cellular chemical homeostasis,BP
GO:0098609,3.5920557116530176e-10,1,34,839,cell-cell adhesion,BP
GO:0042803,3.7311445530556653e-10,1,34,860,protein homodimerization activity,MF
GO:0005216,3.7678248537235326e-10,1,24,416,ion channel activity,MF
GO:0001664,3.7753962376471454e-10,1,19,281,G protein-coupled receptor binding,MF
GO:0052548,3.872476941106125e-10,1,23,424,regulation of endopeptidase activity,BP
GO:0044281,3.8949304542344873e-10,1,58,2115,small molecule metabolic process,BP
GO:0097458,4.0001118303787987e-10,1,52,1728,neuron part,CC
GO:0098805,4.4413848585165663e-10,1,50,1663,whole membrane,CC
GO:0015267,4.488605483157818e-10,1,25,455,channel activity,MF
GO:0022803,4.711690326634743e-10,1,25,456,passive transmembrane transporter activity,MF
GO:0045088,4.768441430953179e-10,1,24,453,regulation of innate immune response,BP
GO:0015672,4.994594521739813e-10,1,26,524,monovalent inorganic cation transport,BP
GO:0051051,6.091867646942816e-10,1,25,524,negative regulation of transport,BP
GO:0022838,6.608596279133771e-10,1,24,428,substrate-specific channel activity,MF
GO:0005125,6.790364298944116e-10,1,17,220,cytokine activity,MF
GO:0045069,7.426188535232234e-10,0.9999999999511237,12,95,regulation of viral genome replication,BP
GO:0045071,7.448248007756065e-10,0.9999999999661089,10,59,negative regulation of viral genome replication,BP
GO:0002790,7.478187160071753e-10,1,28,626,peptide secretion,BP
GO:0005783,8.190669815725321e-10,1,54,1907,endoplasmic reticulum,CC
GO:0120025,8.813577190937928e-10,1,58,2106,plasma membrane bounded cell projection,CC
GO:0051270,8.831780536551071e-10,1,37,1099,regulation of cellular component movement,BP
GO:0043269,8.85254350249743e-10,1,30,699,regulation of ion transport,BP
GO:0000166,9.158826625307599e-10,1,58,2112,nucleotide binding,MF
GO:1901265,9.297671825607979e-10,1,58,2113,nucleoside phosphate binding,MF
GO:0046649,9.298765218811889e-10,1,29,664,lymphocyte activation,BP
GO:0051336,9.318246939026425e-10,1,42,1295,regulation of hydrolase activity,BP
GO:1901363,9.791394196396447e-10,1,119,6191,heterocyclic compound binding,MF
GO:0008015,9.848988681657048e-10,1,26,543,blood circulation,BP
GO:0001505,1.0624588466731477e-9,1,21,353,regulation of neurotransmitter levels,BP
GO:0044706,1.0911336904787403e-9,1,17,224,multi-multicellular organism process,BP
GO:0031349,1.1141611168947564e-9,1,25,520,positive regulation of defense response,BP
GO:0022008,1.1517865509845982e-9,1,49,1623,neurogenesis,BP
GO:0042995,1.2002819097464534e-9,1,59,2181,cell projection,CC
GO:0002484,1.2324144288142614e-9,0.9999999999977291,5,6,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,BP
GO:0002486,1.2324144288142614e-9,0.9999999999977291,5,6,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",BP
GO:0060548,1.2608005499023385e-9,1,36,1021,negative regulation of cell death,BP
GO:0000165,1.3382596319629578e-9,1,35,958,MAPK cascade,BP
GO:0005539,1.3500509813469846e-9,1,17,228,glycosaminoglycan binding,MF
GO:0003013,1.4084349345495115e-9,1,26,553,circulatory system process,BP
GO:0038023,1.7678186690528388e-9,1,46,1449,signaling receptor activity,MF
GO:0002253,1.7749270748278028e-9,1,27,611,activation of immune response,BP
GO:0023014,1.8079224030695116e-9,1,35,969,signal transduction by protein phosphorylation,BP
GO:0055074,1.9039106811666543e-9,1,24,473,calcium ion homeostasis,BP
GO:0005829,2.025663679241428e-9,1,103,5081,cytosol,CC
GO:1990573,2.088307566057684e-9,0.9999999999173911,9,43,potassium ion import across plasma membrane,BP
GO:0045055,2.201532676781629e-9,1,31,791,regulated exocytosis,BP
GO:0097159,2.2285254941999954e-9,1,119,6278,organic cyclic compound binding,MF
GO:1903901,2.320442716118008e-9,0.9999999998469502,11,85,negative regulation of viral life cycle,BP
GO:0032553,2.3783867304479934e-9,1,53,1882,ribonucleotide binding,MF
GO:2000116,2.580482221224294e-9,1,17,240,regulation of cysteine-type endopeptidase activity,BP
GO:0002367,2.6500451371514996e-9,0.9999999997917398,12,102,cytokine production involved in immune response,BP
GO:0044057,2.7092892762290068e-9,0.9999999994920142,27,615,regulation of system process,BP
GO:0002711,2.9047105308795503e-9,0.9999999998748876,9,47,positive regulation of T cell mediated immunity,BP
GO:0016192,2.994414789864369e-9,1,54,1999,vesicle-mediated transport,BP
GO:0001818,3.191968143811532e-9,1,18,296,negative regulation of cytokine production,BP
GO:0030162,3.4089318418588966e-9,0.9999999993052144,30,767,regulation of proteolysis,BP
GO:0022414,3.420831943043192e-9,1,44,1430,reproductive process,BP
GO:0071495,3.4943244517351877e-9,1,43,1396,cellular response to endogenous stimulus,BP
GO:0000003,3.61975698733563e-9,1,44,1433,reproduction,BP
GO:0009725,3.664501793007394e-9,1,35,990,response to hormone,BP
GO:0002718,3.729331466126064e-9,0.9999999997426242,11,84,regulation of cytokine production involved in immune response,BP
GO:0042611,3.752349787490971e-9,0.9999999999207849,7,22,MHC protein complex,CC
GO:1903530,3.8737255630218485e-9,0.9999999992069648,30,753,regulation of secretion by cell,BP
GO:0006813,3.903896945375894e-9,1,17,240,potassium ion transport,BP
GO:0008217,4.355944133914918e-9,0.9999999994875336,15,184,regulation of blood pressure,BP
GO:0060429,4.443735328258107e-9,1,41,1291,epithelium development,BP
GO:0002476,4.606347941141732e-9,0.9999999999820817,5,7,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP
GO:0006887,4.626571112853566e-9,0.9999999989876536,33,900,exocytosis,BP
GO:0001913,4.634565737161956e-9,0.9999999997880435,9,49,T cell mediated cytotoxicity,BP
GO:0032555,4.74408128272656e-9,1,52,1866,purine ribonucleotide binding,MF
GO:0060089,4.907288556194111e-9,1,46,1503,molecular transducer activity,MF
GO:0043410,4.955752698153022e-9,0.9999999991011149,25,545,positive regulation of MAPK cascade,BP
GO:0051047,5.874469632126382e-9,0.9999999990334815,22,428,positive regulation of secretion,BP
GO:0017076,5.903827498314343e-9,1,52,1879,purine nucleotide binding,MF
GO:0010107,5.909536549996966e-9,0.9999999997226712,9,48,potassium ion import,BP
GO:0002709,6.148657484972205e-9,0.9999999996301422,10,69,regulation of T cell mediated immunity,BP
GO:0071804,6.25072051026985e-9,1,16,217,cellular potassium ion transport,BP
GO:0071805,6.25072051026985e-9,1,16,217,potassium ion transmembrane transport,BP
GO:0015077,6.3519151730821696e-9,0.9999999989941651,21,378,monovalent inorganic cation transmembrane transporter activity,MF
GO:0006874,6.374432977554328e-9,0.9999999989068034,23,460,cellular calcium ion homeostasis,BP
GO:0043069,6.617030649386707e-9,0.9999999985339416,33,930,negative regulation of programmed cell death,BP
GO:0002483,6.829224332185433e-9,0.999999999909901,6,14,antigen processing and presentation of endogenous peptide antigen,BP
GO:0019885,6.829224332185433e-9,0.999999999909901,6,14,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP
GO:0031090,7.077152438311833e-9,1,68,2898,organelle membrane,CC
GO:0050900,7.2265841583646776e-9,0.9999999987985986,22,437,leukocyte migration,BP
GO:0030855,7.285301335562275e-9,0.9999999984730258,30,774,epithelial cell differentiation,BP
GO:0098739,7.46222974358647e-9,0.9999999993527735,12,110,import across plasma membrane,BP
GO:0002764,8.271158845233898e-9,0.9999999984655544,25,562,immune response-regulating signaling pathway,BP
GO:0007565,8.602615492157505e-9,0.999999998921976,15,194,female pregnancy,BP
GO:0002700,8.693572609790507e-9,0.9999999991259856,13,139,regulation of production of molecular mediator of immune response,BP
GO:0072507,9.120017030886647e-9,0.9999999983537436,24,514,divalent inorganic cation homeostasis,BP
GO:0035639,9.978708269470108e-9,1,50,1800,purine ribonucleoside triphosphate binding,MF
GO:0048699,1.0606565741629645e-8,1,45,1524,generation of neurons,BP
GO:0050688,1.0984225441305937e-8,0.9999999992935787,10,73,regulation of defense response to virus,BP
GO:0002440,1.1427182414444437e-8,1,15,200,production of molecular mediator of immune response,BP
GO:0002475,1.1967070853047127e-8,0.9999999998187865,6,15,antigen processing and presentation via MHC class Ib,BP
GO:0007610,1.208262232519569e-8,0.9999999972431431,26,597,behavior,BP
GO:0002720,1.2147421723164839e-8,0.9999999993708526,9,54,positive regulation of cytokine production involved in immune response,BP
GO:0070661,1.2335952210204368e-8,0.9999999982519953,18,298,leukocyte proliferation,BP
GO:0098657,1.3251216798262021e-8,0.9999999971020193,31,841,import into cell,BP
GO:0043066,1.4732211997910544e-8,0.9999999967036296,32,909,negative regulation of apoptotic process,BP
GO:0019079,1.4797986763558716e-8,0.9999999986178685,12,122,viral genome replication,BP
GO:0015276,1.527203220733427e-8,0.9999999983774721,13,139,ligand-gated ion channel activity,MF
GO:0022834,1.527203220733427e-8,0.9999999983774721,13,139,ligand-gated channel activity,MF
GO:0019932,1.5669319125306873e-8,0.9999999968698452,22,442,second-messenger-mediated signaling,BP
GO:0071705,1.6576458763302665e-8,1,58,2372,nitrogen compound transport,BP
GO:0002824,1.831991240828283e-8,0.9999999984980067,11,99,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP
GO:0002444,1.929456633923292e-8,0.9999999957826919,24,550,myeloid leukocyte mediated immunity,BP
GO:0072503,1.9883998480218157e-8,0.999999995807981,23,494,cellular divalent inorganic cation homeostasis,BP
GO:0044422,2.0606663492351905e-8,1,164,10028,organelle part,CC
GO:0043408,2.1106728258518222e-8,0.9999999946239122,29,768,regulation of MAPK cascade,BP
GO:0098797,2.2521602199198532e-8,0.9999999948700075,25,569,plasma membrane protein complex,CC
GO:0001101,2.504713741032993e-8,0.9999999955501595,19,342,response to acid chemical,BP
GO:0008270,2.583481463619521e-8,0.999999993202088,30,808,zinc ion binding,MF
GO:0010466,2.6668966831525023e-8,0.9999999964925633,16,260,negative regulation of peptidase activity,BP
GO:0042110,2.705731275497535e-8,0.9999999944260385,22,463,T cell activation,BP
GO:0050678,2.7580443424640164e-8,0.9999999950590409,19,379,regulation of epithelial cell proliferation,BP
GO:0007268,2.8457659744186746e-8,0.9999999928430114,28,702,chemical synaptic transmission,BP
GO:0098916,2.8457659744186746e-8,0.9999999928430114,28,702,anterograde trans-synaptic signaling,BP
GO:0002274,2.964682040758941e-8,0.9999999929312867,26,650,myeloid leukocyte activation,BP
GO:0002821,3.107311103648249e-8,0.9999999973063871,11,104,positive regulation of adaptive immune response,BP
GO:0006820,3.26657046776507e-8,0.9999999921792655,26,629,anion transport,BP
GO:0010035,3.350592663117874e-8,0.9999999924650298,24,562,response to inorganic substance,BP
GO:0098588,3.433855666675416e-8,1,53,2080,bounding membrane of organelle,CC
GO:0044249,3.4980186816314284e-8,1,114,6140,cellular biosynthetic process,BP
GO:0099537,3.627057957820338e-8,0.9999999907765552,28,710,trans-synaptic signaling,BP
GO:0031348,3.6907784266842403e-8,0.9999999953792348,15,239,negative regulation of defense response,BP
GO:0043086,3.7594064704695876e-8,0.9999999901730108,29,813,negative regulation of catalytic activity,BP
GO:0042493,3.8735518891852116e-8,0.9999999887596877,34,1022,response to drug,BP
GO:0006935,3.948040520880793e-8,0.9999999904584524,26,643,chemotaxis,BP
GO:0002819,3.978463730841851e-8,0.999999995378123,13,159,regulation of adaptive immune response,BP
GO:0042330,4.154045249794424e-8,0.9999999899356339,26,645,taxis,BP
GO:1901576,4.2215901865602554e-8,1,115,6231,organic substance biosynthetic process,BP
GO:0030182,4.234069858857291e-8,0.9999999888836181,41,1365,neuron differentiation,BP
GO:0099536,4.2976802189220237e-8,0.9999999889860195,28,716,synaptic signaling,BP
GO:0048666,4.360030865077649e-8,0.9999999868568418,36,1110,neuron development,BP
GO:0043299,4.577292146429804e-8,0.9999999899017249,23,533,leukocyte degranulation,BP
GO:0002366,4.7385875473783487e-8,0.9999999876751737,27,706,leukocyte activation involved in immune response,BP
GO:0008104,4.9568327160611435e-8,1,63,2761,protein localization,BP
GO:0002263,5.389754235771369e-8,0.9999999858913448,27,710,cell activation involved in immune response,BP
GO:0007159,5.5811795028532604e-8,0.9999999901199004,18,336,leukocyte cell-cell adhesion,BP
GO:0051346,5.957218442297209e-8,0.9999999876841116,21,463,negative regulation of hydrolase activity,BP
GO:0034762,6.424152321736609e-8,0.9999999845809704,24,569,regulation of transmembrane transport,BP
GO:0050715,6.52840672068984e-8,0.9999999929573183,12,138,positive regulation of cytokine secretion,BP
GO:0002275,6.640807426335392e-8,0.9999999845994092,23,543,myeloid cell activation involved in immune response,BP
GO:0099094,6.796292561229699e-8,0.9999999936205112,11,106,ligand-gated cation channel activity,MF
GO:0001914,6.971043866957268e-8,0.9999999974950036,7,32,regulation of T cell mediated cytotoxicity,BP
GO:0060326,7.107458602359097e-8,0.9999999879684361,17,303,cell chemotaxis,BP
GO:0005201,7.1914226348947e-8,0.9999999911926205,13,163,extracellular matrix structural constituent,MF
GO:0062023,7.31192788410694e-8,0.9999999850308307,20,405,collagen-containing extracellular matrix,CC
GO:0043085,7.54650322708311e-8,0.9999999798442134,41,1427,positive regulation of catalytic activity,BP
GO:0009058,7.850270298700165e-8,1,115,6311,biosynthetic process,BP
GO:0045089,8.376870366350184e-8,0.9999999839172301,19,381,positive regulation of innate immune response,BP
GO:0044446,8.588298268873391e-8,1,157,9727,intracellular organelle part,CC
GO:0015079,9.449817692499714e-8,0.9999999881465254,13,159,potassium ion transmembrane transporter activity,MF
GO:0010951,9.601866959183085e-8,0.9999999855843391,15,248,negative regulation of endopeptidase activity,BP
GO:0061743,9.682318028643446e-8,0.999999999769728,4,5,motor learning,BP
GO:0005261,1.0313179108628906e-7,0.9999999810185211,18,319,cation channel activity,MF
GO:0002822,1.0604642076574773e-7,0.9999999879953705,12,144,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP
GO:0030155,1.1427930007381089e-7,0.9999999698127128,26,690,regulation of cell adhesion,BP
GO:0099503,1.1931966544861542e-7,0.9999999634189615,32,986,secretory vesicle,CC
GO:0050708,1.2185298021759697e-7,0.9999999730075173,21,472,regulation of protein secretion,BP
GO:0019883,1.2293090110541652e-7,0.9999999968986376,6,21,antigen processing and presentation of endogenous antigen,BP
GO:1903706,1.3114686069747514e-7,0.9999999708160499,21,475,regulation of hemopoiesis,BP
GO:1901652,1.3631387105688265e-7,0.9999999682996681,22,522,response to peptide,BP
GO:1901698,1.3872036077329317e-7,0.999999955531431,34,1089,response to nitrogen compound,BP
GO:0002673,1.413893167600242e-7,0.999999987713196,10,98,regulation of acute inflammatory response,BP
GO:0008144,1.4959279566740908e-7,0.9999999573464224,46,1718,drug binding,MF
GO:0007600,1.5100497810950047e-7,0.9999999532428616,32,953,sensory perception,BP
GO:0045184,1.5148935535711217e-7,1,51,2111,establishment of protein localization,BP
GO:0002702,1.5210761760864893e-7,0.9999999867001758,10,95,positive regulation of production of molecular mediator of immune response,BP
GO:0051259,1.5285460639193067e-7,0.9999999628266039,23,567,protein complex oligomerization,BP
GO:0035150,1.6352073030938596e-7,0.9999999807104346,12,145,regulation of tube size,BP
GO:0055078,1.650634677485334e-7,0.9999999905911077,8,52,sodium ion homeostasis,BP
GO:0044432,1.759218054544005e-7,0.9999999417628278,39,1358,endoplasmic reticulum part,CC
GO:0045202,1.843479547052898e-7,0.9999999381615379,36,1172,synapse,CC
GO:0022839,1.908634632802945e-7,0.9999999625548753,18,334,ion gated channel activity,MF
GO:0002757,2.0001372293495e-7,0.9999999524217414,22,528,immune response-activating signal transduction,BP
GO:0005126,2.0789581685114264e-7,0.9999999637451386,16,287,cytokine receptor binding,MF
GO:0098712,2.1941812628664034e-7,0.9999999966853306,5,13,L-glutamate import across plasma membrane,BP
GO:1903039,2.205830833621522e-7,0.9999999674569672,14,217,positive regulation of leukocyte cell-cell adhesion,BP
GO:0043281,2.2120082349780988e-7,0.9999999673630618,14,216,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP
GO:0016787,2.2255354567564053e-7,1,58,2515,hydrolase activity,MF
GO:0001912,2.3478954272761955e-7,0.9999999858954717,8,55,positive regulation of leukocyte mediated cytotoxicity,BP
GO:0042119,2.367151693093611e-7,0.9999999450393966,21,496,neutrophil activation,BP
GO:0009612,2.421783921733995e-7,0.9999999640342392,14,210,response to mechanical stimulus,BP
GO:0030595,2.5478567271172345e-7,0.999999961938627,14,222,leukocyte chemotaxis,BP
GO:0090087,2.554046666360074e-7,0.9999999289622729,26,728,regulation of peptide transport,BP
GO:0043491,2.582536258003801e-7,0.9999999580733665,15,269,protein kinase B signaling,BP
GO:0045785,2.583304772695207e-7,0.9999999453376563,19,402,positive regulation of cell adhesion,BP
GO:0050867,2.615680467274787e-7,0.9999999504466168,17,326,positive regulation of cell activation,BP
GO:0044463,2.620869474155389e-7,0.9999999098946127,41,1470,cell projection part,CC
GO:0120038,2.620869474155389e-7,0.9999999098946127,41,1470,plasma membrane bounded cell projection part,CC
GO:0042277,2.725351280552768e-7,0.9999999514933133,16,287,peptide binding,MF
GO:0032989,2.74094941832314e-7,0.9999999080359422,35,1145,cellular component morphogenesis,BP
GO:0022836,2.7644503607580385e-7,0.9999999443316809,18,343,gated channel activity,MF
GO:1901681,2.8254033981449434e-7,0.9999999531388825,15,250,sulfur compound binding,MF
GO:0055067,2.835763901327442e-7,0.999999964651408,12,155,monovalent inorganic cation homeostasis,BP
GO:0036230,2.890549174744324e-7,0.999999932037061,21,502,granulocyte activation,BP
GO:0002791,3.1175129156376776e-7,0.999999926361042,21,500,regulation of peptide secretion,BP
GO:0030141,3.119454798576785e-7,0.9999999074472142,28,832,secretory granule,CC
GO:0098656,3.3367621461459735e-7,0.9999999396954872,16,287,anion transmembrane transport,BP
GO:0002683,3.3544247846988764e-7,0.9999999238051429,20,462,negative regulation of immune system process,BP
GO:0001916,3.4770870797397725e-7,0.9999999890903328,6,25,positive regulation of T cell mediated cytotoxicity,BP
GO:0051938,3.5306358568512746e-7,0.9999999939480777,5,14,L-glutamate import,BP
GO:0043005,3.560834862429045e-7,0.9999998736397899,38,1314,neuron projection,CC
GO:0044703,3.674551567285311e-7,0.999999879892678,32,1016,multi-organism reproductive process,BP
GO:0042562,3.742142506715419e-7,0.999999963676414,10,103,hormone binding,MF
GO:1903037,3.755223836914145e-7,0.9999999314289773,16,303,regulation of leukocyte cell-cell adhesion,BP
GO:1901565,4.0901152703080814e-7,0.9999998560855097,37,1297,organonitrogen compound catabolic process,BP
GO:0070201,4.110412326106638e-7,0.9999998827060125,26,745,regulation of establishment of protein localization,BP
GO:0051223,4.1227867727380097e-7,0.9999998857346657,25,698,regulation of protein transport,BP
GO:0005178,4.1553413099798413e-7,0.9999999525503115,11,132,integrin binding,MF
GO:0070848,4.187522540715687e-7,0.9999998804041718,26,737,response to growth factor,BP
GO:0050865,4.2674637546092787e-7,0.9999998930288075,22,546,regulation of cell activation,BP
GO:0007611,4.843482910224329e-7,0.9999999160546575,15,259,learning or memory,BP
GO:0004888,4.845476258158052e-7,0.9999998253362681,37,1243,transmembrane signaling receptor activity,MF
GO:1902495,4.974041691620144e-7,0.9999999013016514,17,324,transmembrane transporter complex,CC
GO:0051251,5.136950502446097e-7,0.9999999104923268,15,265,positive regulation of lymphocyte activation,BP
GO:0032102,5.188520195395824e-7,0.9999998964628718,17,364,negative regulation of response to external stimulus,BP
GO:0010721,5.241132962293487e-7,0.9999998954630395,17,344,negative regulation of cell development,BP
GO:0007167,5.517364388077791e-7,0.9999998161831185,32,1048,enzyme linked receptor protein signaling pathway,BP
GO:0050890,5.606351900677481e-7,0.9999998944933834,16,299,cognition,BP
GO:0009887,5.611854809165873e-7,0.9999998094076793,33,1067,animal organ morphogenesis,BP
GO:0002831,5.636172871255459e-7,0.999999933437726,11,139,regulation of response to biotic stimulus,BP
GO:0019637,5.961587502307054e-7,0.9999997932431682,34,1175,organophosphate metabolic process,BP
GO:0050870,6.090485796939215e-7,0.9999999103344693,13,201,positive regulation of T cell activation,BP
GO:0098796,6.115541287500369e-7,0.9999997876863986,34,1162,membrane protein complex,CC
GO:0006821,6.166226365280763e-7,0.9999999365629989,10,108,chloride transport,BP
GO:0042060,6.189500333767696e-7,0.9999998412316421,22,564,wound healing,BP
GO:0098659,6.415574593577487e-7,0.9999999444721372,9,83,inorganic cation import across plasma membrane,BP
GO:0099587,6.415574593577487e-7,0.9999999444721372,9,83,inorganic ion import across plasma membrane,BP
GO:0008201,6.425961976529597e-7,0.9999999130631,12,169,heparin binding,MF
GO:0071363,6.593904177209213e-7,0.9999998119540902,25,708,cellular response to growth factor stimulus,BP
GO:1990351,6.657233199164624e-7,0.9999998644558675,17,332,transporter complex,CC
GO:0071396,6.685996330160094e-7,0.9999998210808351,23,609,cellular response to lipid,BP
GO:0032526,6.905960463307409e-7,0.9999999280474466,10,108,response to retinoic acid,BP
GO:0002283,6.962716881971831e-7,0.999999834016232,20,486,neutrophil activation involved in immune response,BP
GO:0002521,7.491947608875432e-7,0.9999998129549387,21,514,leukocyte differentiation,BP
GO:0000902,7.569260040381313e-7,0.9999997429589481,32,1036,cell morphogenesis,BP
GO:0002696,7.616942175095894e-7,0.9999998526032284,16,312,positive regulation of leukocyte activation,BP
GO:0044456,8.95739518673933e-7,0.9999997055103215,30,939,synapse part,CC
GO:1903532,9.426605135714102e-7,0.9999997915788978,18,399,positive regulation of secretion by cell,BP
GO:0002446,9.7637597554362e-7,0.9999997616202944,20,497,neutrophil mediated immunity,BP
GO:0032480,9.847884072797958e-7,0.9999999446912137,7,46,negative regulation of type I interferon production,BP
GO:0003018,1.078500882215414e-6,0.999999846427867,12,174,vascular process in circulatory system,BP
GO:0043549,1.1238112269731106e-6,0.9999996425747275,28,870,regulation of kinase activity,BP
GO:0031343,1.1282747437905276e-6,0.9999999148840155,8,67,positive regulation of cell killing,BP
GO:0019438,1.1699296397619892e-6,0.9999995869587155,84,4328,aromatic compound biosynthetic process,BP
GO:0035296,1.1800294765995696e-6,0.9999998493077625,11,144,regulation of tube diameter,BP
GO:0050880,1.1800294765995696e-6,0.9999998493077625,11,144,regulation of blood vessel size,BP
GO:0097746,1.1800294765995696e-6,0.9999998493077625,11,144,regulation of blood vessel diameter,BP
GO:0002698,1.1993642496670358e-6,0.9999998663684002,10,120,negative regulation of immune effector process,BP
GO:0030099,1.2472625129612014e-6,0.9999997184653658,18,415,myeloid cell differentiation,BP
GO:1901362,1.2514005292868425e-6,0.9999995555743755,86,4477,organic cyclic compound biosynthetic process,BP
GO:0014070,1.2781321102298253e-6,0.9999995812817121,29,916,response to organic cyclic compound,BP
GO:0030198,1.440307239187176e-6,0.9999996887868461,17,367,extracellular matrix organization,BP
GO:0022409,1.5133443972157679e-6,0.999999732307951,14,254,positive regulation of cell-cell adhesion,BP
GO:0006636,1.5578179870827514e-6,0.9999999049330404,7,53,unsaturated fatty acid biosynthetic process,BP
GO:0010628,1.563093517675823e-6,0.9999993919294292,48,2006,positive regulation of gene expression,BP
GO:0010243,1.5838666506897367e-6,0.9999994638924311,30,998,response to organonitrogen compound,BP
GO:0022804,1.5974173286753416e-6,0.9999996522747806,17,361,active transmembrane transporter activity,MF
GO:0043123,1.6305831283509381e-6,0.9999997578044052,12,184,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP
GO:0003073,1.7062252778748973e-6,0.9999998322633313,9,94,regulation of systemic arterial blood pressure,BP
GO:0032880,1.7076531570080303e-6,0.9999994197238684,30,1011,regulation of protein localization,BP
GO:0001667,1.7158072823048532e-6,0.999999602599969,18,461,ameboidal-type cell migration,BP
GO:1903708,1.748274291275788e-6,0.9999997384996857,12,185,positive regulation of hemopoiesis,BP
GO:0045859,1.823987408438483e-6,0.9999994329679759,26,792,regulation of protein kinase activity,BP
GO:0002694,1.8327737686350695e-6,0.999999533311409,20,503,regulation of leukocyte activation,BP
GO:0051249,1.8881266860403444e-6,0.9999995604574308,18,416,regulation of lymphocyte activation,BP
GO:0006814,2.0025484535249455e-6,0.9999996663737178,13,216,sodium ion transport,BP
GO:0043062,2.1032430007947394e-6,0.9999995064353678,18,421,extracellular structure organization,BP
GO:0044283,2.1544554518535794e-6,0.9999993238140098,26,807,small molecule biosynthetic process,BP
GO:0032991,2.1560682399924025e-6,0.999998974350694,98,5832,protein-containing complex,CC
GO:2000181,2.270209596154321e-6,0.9999997242208162,10,176,negative regulation of blood vessel morphogenesis,BP
GO:2000696,2.2907208261859135e-6,0.9999999369667255,5,19,regulation of epithelial cell differentiation involved in kidney development,BP
GO:0015833,2.3015217533339355e-6,0.9999990343479354,47,2033,peptide transport,BP
GO:0018130,2.343853239875916e-6,0.9999989213853661,83,4318,heterocycle biosynthetic process,BP
GO:0015081,2.4204126609645998e-6,0.9999996662775005,11,149,sodium ion transmembrane transporter activity,MF
GO:0036477,2.4244485958806587e-6,0.9999992146497864,27,841,somatodendritic compartment,CC
GO:0045861,2.532535126511494e-6,0.9999994596494851,16,359,negative regulation of proteolysis,BP
GO:0043312,2.54657459185057e-6,0.999999364387279,19,483,neutrophil degranulation,BP
GO:0071496,2.546748239377507e-6,0.9999994570482681,16,338,cellular response to external stimulus,BP
GO:0007188,2.6235289117443564e-6,0.9999995505444195,13,222,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,BP
GO:0034654,2.6898320120328036e-6,0.9999986481233294,82,4255,nucleobase-containing compound biosynthetic process,BP
GO:0002886,2.7891929281677863e-6,0.9999998130771856,7,56,regulation of myeloid leukocyte mediated immunity,BP
GO:0010959,2.9958604626295364e-6,0.9999993144087373,17,393,regulation of metal ion transport,BP
GO:0008593,3.0715968989693393e-6,0.999999673363097,9,105,regulation of Notch signaling pathway,BP
GO:0033209,3.150845463967686e-6,0.9999995513545986,11,168,tumor necrosis factor-mediated signaling pathway,BP
GO:0001653,3.162870629578332e-6,0.9999995510634584,11,152,peptide receptor activity,MF
GO:0072643,3.209868284233541e-6,0.999999902413246,5,22,interferon-gamma secretion,BP
GO:0051260,3.2181461848643285e-6,0.999999300454337,16,352,protein homooligomerization,BP
GO:0060627,3.2413732123398243e-6,0.9999991412764333,20,531,regulation of vesicle-mediated transport,BP
GO:0015031,3.2498211941664032e-6,0.999998595160969,46,1996,protein transport,BP
GO:0033218,3.34538922953281e-6,0.9999992707579061,16,347,amide binding,MF
GO:0045177,3.3798607638142952e-6,0.9999992196632614,17,386,apical part of cell,CC
GO:0042886,3.431757961279085e-6,0.9999985398783817,47,2063,amide transport,BP
GO:0046651,3.5132796556953042e-6,0.9999993282460037,14,272,lymphocyte proliferation,BP
GO:0030424,3.5396203266420203e-6,0.9999989845801169,22,607,axon,CC
GO:0050863,3.6387868024154912e-6,0.9999992500689373,15,313,regulation of T cell activation,BP
GO:0043122,3.7056645766123944e-6,0.9999993432233307,13,238,regulation of I-kappaB kinase/NF-kappaB signaling,BP
GO:0032943,3.826812359602597e-6,0.9999992626434719,14,274,mononuclear cell proliferation,BP
GO:0005198,3.855957584575557e-6,0.9999988148019107,24,743,structural molecule activity,MF
GO:0031984,3.872753185902913e-6,0.9999983648051799,42,1712,organelle subcompartment,CC
GO:0097529,4.026907816410203e-6,0.9999993437483459,12,209,myeloid leukocyte migration,BP
GO:0050691,4.158876099882531e-6,0.9999997866756143,6,37,regulation of defense response to virus by host,BP
GO:0007568,4.1867013201282906e-6,0.9999991264699684,15,321,aging,BP
GO:0005242,4.240254500464936e-6,0.9999998659434632,5,20,inward rectifier potassium channel activity,MF
GO:0050707,4.354024147464047e-6,0.9999992849161276,12,209,regulation of cytokine secretion,BP
GO:0001660,4.534600632964716e-6,0.9999999327742944,4,10,fever generation,BP
GO:0005524,4.558706925928549e-6,0.999998151714273,38,1463,ATP binding,MF
GO:0032559,4.731991599007386e-6,0.9999980540133523,39,1521,adenyl ribonucleotide binding,MF
GO:0030054,4.8126990877596304e-6,0.9999981187438568,35,1301,cell junction,CC
GO:0006145,4.871452700695312e-6,0.9999999868925316,3,4,purine nucleobase catabolic process,BP
GO:1901343,4.8735514747745855e-6,0.9999993528175247,10,188,negative regulation of vasculature development,BP
GO:0034765,4.886509176133968e-6,0.9999987225995174,19,484,regulation of ion transmembrane transport,BP
GO:0015813,5.00109253292076e-6,0.9999998319712847,5,23,L-glutamate transmembrane transport,BP
GO:0030414,5.026275316850323e-6,0.9999992462166789,11,180,peptidase inhibitor activity,MF
GO:0050804,5.034226728448414e-6,0.9999987396855569,18,436,modulation of chemical synaptic transmission,BP
GO:0051248,5.139638986828247e-6,0.9999981123176835,31,1183,negative regulation of protein metabolic process,BP
GO:0099177,5.167494885624605e-6,0.9999987037700695,18,437,regulation of trans-synaptic signaling,BP
GO:0070777,5.272939957946604e-6,0.9999999854285063,3,4,D-aspartate transport,BP
GO:0070779,5.272939957946604e-6,0.9999999854285063,3,4,D-aspartate import across plasma membrane,BP
GO:0043235,5.42893983002253e-6,0.9999986995979114,17,396,receptor complex,CC
GO:0005794,5.48301833074661e-6,0.9999977302903362,39,1561,Golgi apparatus,CC
GO:0070374,5.543361423205832e-6,0.9999990669350661,12,213,positive regulation of ERK1 and ERK2 cascade,BP
GO:0061134,5.565502246943836e-6,0.9999990623600011,12,217,peptidase regulator activity,MF
GO:0030554,5.570108003087052e-6,0.9999976929870913,39,1532,adenyl nucleotide binding,MF
GO:0089718,5.582606724768284e-6,0.9999998080911932,5,23,amino acid import across plasma membrane,BP
GO:0001659,5.673350295265986e-6,0.9999991391814251,11,173,temperature homeostasis,BP
GO:0050839,5.764808682523569e-6,0.9999984744261736,19,499,cell adhesion molecule binding,MF
GO:0051480,5.848687790159471e-6,0.9999986657928137,16,359,regulation of cytosolic calcium ion concentration,BP
GO:0031256,6.003552040222703e-6,0.9999990837219154,11,172,leading edge membrane,CC
GO:0045834,6.169203495769851e-6,0.9999991648997562,10,146,positive regulation of lipid metabolic process,BP
GO:0007204,6.257474660543181e-6,0.9999986494288319,15,321,positive regulation of cytosolic calcium ion concentration,BP
GO:0043588,6.459871293271895e-6,0.9999984298787192,17,418,skin development,BP
GO:0001936,6.673638305814727e-6,0.9999990826696747,10,177,regulation of endothelial cell proliferation,BP
GO:0035725,6.834458444628614e-6,0.9999990655338385,10,139,sodium ion transmembrane transport,BP
GO:0042605,6.9991489034023615e-6,0.9999997477884918,5,23,peptide antigen binding,MF
GO:0005768,7.042901765107227e-6,0.9999975765793372,27,904,endosome,CC
GO:0031328,7.259668493623934e-6,0.9999967655534862,46,1988,positive regulation of cellular biosynthetic process,BP
GO:1902107,7.369927507220266e-6,0.9999989821488661,10,144,positive regulation of leukocyte differentiation,BP
GO:0098793,7.4763875467973354e-6,0.9999979847815554,19,492,presynapse,CC
GO:0070372,7.531996267942412e-6,0.9999984550674921,14,298,regulation of ERK1 and ERK2 cascade,BP
GO:0032870,7.804851986105411e-6,0.9999975668094299,23,703,cellular response to hormone stimulus,BP
GO:0010468,7.89384345442605e-6,0.9999957132391486,86,5022,regulation of gene expression,BP
GO:0007596,8.05602425172604e-6,0.9999982219970349,15,335,blood coagulation,BP
GO:0090066,8.355895039516556e-6,0.9999977287223357,19,505,regulation of anatomical structure size,BP
GO:0010623,8.563766167532002e-6,0.9999998394056976,4,12,programmed cell death involved in cell development,BP
GO:0009636,8.783009862812614e-6,0.999997602717171,19,524,response to toxic substance,BP
GO:0042098,9.00242408479982e-6,0.999998561878586,11,184,T cell proliferation,BP
GO:0019882,9.022713087517109e-6,0.9999984033219652,12,223,antigen processing and presentation,BP
GO:0051338,9.172908372973059e-6,0.9999967246729174,28,974,regulation of transferase activity,BP
GO:0007169,9.256565440279808e-6,0.9999970821360995,23,720,transmembrane receptor protein tyrosine kinase signaling pathway,BP
GO:2000117,9.308506944414755e-6,0.999999043563528,8,92,negative regulation of cysteine-type endopeptidase activity,BP
GO:0051092,9.309754526291265e-6,0.9999986769904468,10,150,positive regulation of NF-kappaB transcription factor activity,BP
GO:0050817,9.534090949390565e-6,0.999997864586116,15,341,coagulation,BP
GO:0007599,9.618128539849256e-6,0.9999978442707698,15,340,hemostasis,BP
GO:0002371,9.682228472806071e-6,0.9999998126214242,4,12,dendritic cell cytokine production,BP
GO:0051172,9.767697810153808e-6,0.9999953924295333,52,2479,negative regulation of nitrogen compound metabolic process,BP
GO:0050777,9.769058865304266e-6,0.9999986039209378,10,150,negative regulation of immune response,BP
GO:0070663,9.781647744319555e-6,0.9999982550737846,12,222,regulation of leukocyte proliferation,BP
GO:0050768,9.788997177306594e-6,0.9999979446511602,14,296,negative regulation of neurogenesis,BP
GO:0007588,9.812715340962408e-6,0.9999991942638997,7,63,excretion,BP
GO:0040007,9.884881687249188e-6,0.9999964554453569,28,983,growth,BP
GO:0005581,9.955467480735168e-6,0.9999989704260891,8,87,collagen trimer,CC
GO:0051090,1.042877822761882e-5,0.9999973674576671,17,432,regulation of DNA-binding transcription factor activity,BP
GO:0071556,1.0439109975862645e-5,0.9999995830690048,5,26,integral component of lumenal side of endoplasmic reticulum membrane,CC
GO:0098553,1.0439109975862645e-5,0.9999995830690048,5,26,lumenal side of endoplasmic reticulum membrane,CC
GO:0007612,1.0686139057305263e-5,0.9999984579117397,10,147,learning,BP
GO:0009891,1.084123220056561e-5,0.9999950377919883,46,2021,positive regulation of biosynthetic process,BP
GO:0043090,1.0949643184808227e-5,0.9999995582880357,5,26,amino acid import,BP
GO:1903522,1.1177368756334562e-5,0.9999976245856622,14,298,regulation of blood circulation,BP
GO:0097191,1.1327965711785834e-5,0.9999979485654922,12,224,extrinsic apoptotic signaling pathway,BP
GO:0032269,1.1354036568159547e-5,0.9999958103059311,29,1114,negative regulation of cellular protein metabolic process,BP
GO:0010631,1.1890422998050825e-5,0.9999974507750499,14,351,epithelial cell migration,BP
GO:0051091,1.2045322400398114e-5,0.9999976077250066,13,261,positive regulation of DNA-binding transcription factor activity,BP
GO:0048863,1.2367978234644566e-5,0.9999975383201141,13,257,stem cell differentiation,BP
GO:0007187,1.238865649779656e-5,0.9999975342661006,13,255,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",BP
GO:0007601,1.2748170140377368e-5,0.9999976646724292,12,220,visual perception,BP
GO:0090132,1.3183388556551416e-5,0.9999971466448261,14,354,epithelium migration,BP
GO:0009991,1.3228902729464906e-5,0.9999962794175273,19,531,response to extracellular stimulus,BP
GO:0008528,1.3426282135123288e-5,0.9999980110936543,10,145,G protein-coupled peptide receptor activity,MF
GO:0051896,1.3472095450160985e-5,0.9999975108594288,12,244,regulation of protein kinase B signaling,BP
GO:0050714,1.3636474883920822e-5,0.9999972579607017,13,267,positive regulation of protein secretion,BP
GO:0033674,1.367746053506585e-5,0.9999959927843279,20,573,positive regulation of kinase activity,BP
GO:0007249,1.388719536441381e-5,0.9999972019677722,13,270,I-kappaB kinase/NF-kappaB signaling,BP
GO:0005788,1.4028880335052596e-5,0.9999969545676463,14,308,endoplasmic reticulum lumen,CC
GO:0070371,1.4067097109264929e-5,0.9999969441323265,14,315,ERK1 and ERK2 cascade,BP
GO:0031324,1.421500810873379e-5,0.9999930186872926,54,2643,negative regulation of cellular metabolic process,BP
GO:1903779,1.4787442841775526e-5,0.9999986934817711,7,73,regulation of cardiac conduction,BP
GO:0010575,1.511978327080426e-5,0.9999993376689669,5,29,positive regulation of vascular endothelial growth factor production,BP
GO:0016525,1.5308201447880028e-5,0.9999979706722413,9,174,negative regulation of angiogenesis,BP
GO:0051960,1.5330783093666847e-5,0.9999944831943847,27,928,regulation of nervous system development,BP
GO:0022607,1.555011625819634e-5,0.9999920236768842,61,3104,cellular component assembly,BP
GO:0050953,1.555730478470149e-5,0.9999970892554696,12,224,sensory perception of light stimulus,BP
GO:0001935,1.5701221953540427e-5,0.99999761048606,10,192,endothelial cell proliferation,BP
GO:0045860,1.577873524479978e-5,0.9999955046721855,19,532,positive regulation of protein kinase activity,BP
GO:0031253,1.5804009453454624e-5,0.9999963010115522,15,348,cell projection membrane,CC
GO:0006629,1.620928848542612e-5,0.9999932741436477,35,1409,lipid metabolic process,BP
GO:0022407,1.6225127163871285e-5,0.999995968183102,16,402,regulation of cell-cell adhesion,BP
GO:0031326,1.634749216062728e-5,0.9999908705311227,79,4307,regulation of cellular biosynthetic process,BP
GO:0090130,1.653383885205428e-5,0.9999963456403077,14,360,tissue migration,BP
GO:0004668,1.6572524103579864e-5,0.999999900816603,3,5,protein-arginine deiminase activity,MF
GO:0018101,1.6572524103579864e-5,0.999999900816603,3,5,protein citrullination,BP
GO:0036414,1.6572524103579864e-5,0.999999900816603,3,5,histone citrullination,BP
GO:0005634,1.668066736793517e-5,0.9999898549735434,123,7809,nucleus,CC
GO:0035815,1.6851138053112712e-5,0.9999996061800194,4,14,positive regulation of renal sodium excretion,BP
GO:1901575,1.78469761174362e-5,0.9999915514123395,47,2176,organic substance catabolic process,BP
GO:0032479,1.7936440639220626e-5,0.9999975987921319,9,126,regulation of type I interferon production,BP
GO:0001504,1.7943675171452845e-5,0.9999987808081916,6,46,neurotransmitter uptake,BP
GO:0002479,1.8013265876981928e-05,0.9999983571852173,7,74,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",BP
GO:0070528,1.8371828139288682e-5,0.9999991616000937,5,29,protein kinase C signaling,BP
GO:2000697,1.845396465510244e-5,0.9999998854652334,3,5,negative regulation of epithelial cell differentiation involved in kidney development,BP
GO:0006082,1.953153766925249e-5,0.999992303377974,31,1194,organic acid metabolic process,BP
GO:0006836,1.95854545502407e-5,0.9999959218640004,13,268,neurotransmitter transport,BP
GO:0045335,1.9609829505791836e-5,0.9999973407636713,9,131,phagocytic vesicle,CC
GO:0004857,1.9658881963656483e-5,0.999995304905652,15,373,enzyme inhibitor activity,MF
GO:0032020,1.9851715841776538e-5,0.9999998498133323,3,6,ISG15-protein conjugation,BP
GO:0072511,1.9964734233543174e-5,0.9999944456851381,18,491,divalent inorganic cation transport,BP
GO:0032606,2.007051883047609e-5,0.999997272517761,9,128,type I interferon production,BP
GO:0051961,2.060814491069199e-5,0.9999953637482167,14,316,negative regulation of nervous system development,BP
GO:0008083,2.0673774525535294e-5,0.9999967648250543,10,164,growth factor activity,MF
GO:0042136,2.0764396057446177e-5,0.9999975982345664,8,105,neurotransmitter biosynthetic process,BP
GO:0002675,2.1153261666532523e-5,0.9999989975797262,5,31,positive regulation of acute inflammatory response,BP
GO:0004866,2.1176631998839982e-5,0.9999966713697349,10,173,endopeptidase inhibitor activity,MF
GO:0044271,2.1221605701380425e-5,0.9999877316215267,88,5000,cellular nitrogen compound biosynthetic process,BP
GO:0006959,2.130487866034559e-5,0.9999958711925944,12,254,humoral immune response,BP
GO:0010038,2.1390548773855124e-5,0.9999948558462854,15,364,response to metal ion,BP
GO:0002244,2.147005007614773e-5,0.9999966239325637,10,166,hematopoietic progenitor cell differentiation,BP
GO:0019372,2.1814369967701658e-5,0.9999994373288813,4,16,lipoxygenase pathway,BP
GO:0070207,2.223969199890098e-5,0.9999989310850913,5,32,protein homotrimerization,BP
GO:1901699,2.2323963288054205e-5,0.9999929885360692,21,649,cellular response to nitrogen compound,BP
GO:0030670,2.259909312606863e-5,0.9999978624972332,7,75,phagocytic vesicle membrane,CC
GO:0002573,2.2972167180118283e-5,0.999995925196617,11,203,myeloid leukocyte differentiation,BP
GO:0046113,2.3735089430614802e-5,0.9999998092476929,3,6,nucleobase catabolic process,BP
GO:0031394,2.393599638235864e-5,0.9999998070835707,3,6,positive regulation of prostaglandin biosynthetic process,BP
GO:0048037,2.4578146205918053e-5,0.9999930492356911,18,506,cofactor binding,MF
GO:0042590,2.5146197996491506e-5,0.9999975760632615,7,78,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP
GO:1901360,2.5154387302034333e-5,0.9999847225877232,108,6750,organic cyclic compound metabolic process,BP
GO:0016324,2.538956270878332e-5,0.9999941764901867,14,319,apical plasma membrane,CC
GO:0002478,2.56394150947577e-5,0.999995878370853,10,172,antigen processing and presentation of exogenous peptide antigen,BP
GO:0051347,2.597158626380748e-5,0.9999917568757211,21,650,positive regulation of transferase activity,BP
GO:0002724,2.609718267345356e-5,0.9999987073298324,5,31,regulation of T cell cytokine production,BP
GO:0042692,2.6997968817419412e-5,0.9999933671049502,15,386,muscle cell differentiation,BP
GO:0048872,2.7238006896212106e-5,0.9999945900189515,12,246,homeostasis of number of cells,BP
GO:0017046,2.800377252599341e-5,0.9999979249528821,6,50,peptide hormone binding,MF
GO:0071900,2.810265717687294e-5,0.9999919679784436,18,515,regulation of protein serine/threonine kinase activity,BP
GO:1903531,2.8204941597693655e-5,0.9999948769265711,11,212,negative regulation of secretion by cell,BP
GO:0002793,2.8420036806355275e-5,0.9999938550277164,13,287,positive regulation of peptide secretion,BP
GO:0033198,2.8435499269822413e-5,0.9999985657618571,5,31,response to ATP,BP
GO:0044420,2.853927749148648e-5,0.9999978748528109,6,51,extracellular matrix component,CC
GO:0055038,2.939049657686696e-5,0.9999970962465906,7,78,recycling endosome membrane,CC
GO:0009889,3.0010038134915702e-5,0.9999829386979713,79,4386,regulation of biosynthetic process,BP
GO:0010574,3.006883418039156e-5,0.9999984498666173,5,34,regulation of vascular endothelial growth factor production,BP
GO:0061135,3.0361855113389385e-5,0.9999950137841691,10,180,endopeptidase regulator activity,MF
GO:0010469,3.0771448049825696e-5,0.9999949476269627,10,169,regulation of signaling receptor activity,BP
GO:0005509,3.1096316153237624e-5,0.9999896933402802,22,702,calcium ion binding,MF
GO:0033559,3.277544093086035e-5,0.9999959497261864,8,109,unsaturated fatty acid metabolic process,BP
GO:0050680,3.290273188891876e-5,0.9999951945922471,9,166,negative regulation of epithelial cell proliferation,BP
GO:0017144,3.30372236336818e-5,0.9999883815508551,24,848,drug metabolic process,BP
GO:1904724,3.337510327253512e-5,0.9999974297285683,6,55,tertiary granule lumen,CC
GO:0019838,3.382425698335318e-5,0.9999950717897347,9,137,growth factor binding,MF
GO:0015698,3.3860240647641406e-5,0.9999943767503922,10,169,inorganic anion transport,BP
GO:0002758,3.4127918171517e-5,0.9999924825824434,13,297,innate immune response-activating signal transduction,BP
GO:0043436,3.465652111626939e-5,0.9999861470077591,30,1174,oxoacid metabolic process,BP
GO:0031644,3.5245386545287084e-5,0.9999948359955162,9,138,regulation of neurological system process,BP
GO:0003823,3.554048478622304e-5,0.9999972388885473,6,53,antigen binding,MF
GO:0032655,3.6027097591820515e-5,0.9999971904860033,6,54,regulation of interleukin-12 production,BP
GO:0008016,3.674649059740214e-5,0.9999924672919196,12,252,regulation of heart contraction,BP
GO:0019884,3.707445358857764e-5,0.999993765639333,10,179,antigen processing and presentation of exogenous antigen,BP
GO:0071902,3.7152526228606574e-5,0.9999911653237342,14,334,positive regulation of protein serine/threonine kinase activity,BP
GO:0030662,3.7406728809891574e-5,0.9999937040392224,10,178,coated vesicle membrane,CC
GO:0030947,3.771059658553204e-5,0.9999979489456902,5,36,regulation of vascular endothelial growth factor receptor signaling pathway,BP
GO:0090185,3.79596504874925e-5,0.9999988558289215,4,17,negative regulation of kidney development,BP
GO:0032637,3.9344842354781266e-5,0.999995918299117,7,82,interleukin-8 production,BP
GO:0046633,3.937988738771053e-5,0.9999978573092106,5,33,alpha-beta T cell proliferation,BP
GO:0010573,4.002166140821376e-5,0.999997795651288,5,36,vascular endothelial growth factor production,BP
GO:0043551,4.114264484190388e-5,0.999996709394463,6,55,regulation of phosphatidylinositol 3-kinase activity,BP
GO:0043405,4.122264065505767e-5,0.9999900999926308,14,338,regulation of MAP kinase activity,BP
GO:0043434,4.294727265752669e-5,0.9999884050777778,16,438,response to peptide hormone,BP
GO:0043154,4.403559796350855e-5,0.9999953435845326,7,84,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP
GO:0031649,4.415729516236816e-5,0.9999986158204639,4,17,heat generation,BP
GO:0032412,4.519665838489079e-5,0.9999905256190357,12,260,regulation of ion transmembrane transporter activity,BP
GO:0032615,4.550937097068171e-5,0.9999962884835079,6,56,interleukin-12 production,BP
GO:0042940,4.61085635741938e-5,0.9999994869813102,3,7,D-amino acid transport,BP
GO:0006690,4.6547784753393216e-5,0.9999939401213215,8,115,icosanoid metabolic process,BP
GO:1902041,4.660797827983176e-5,0.9999961736243477,6,58,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP
GO:0044877,4.6802351393451355e-5,0.9999813006263122,29,1135,protein-containing complex binding,MF
GO:0007584,4.7727295394587384e-5,0.9999908021034671,11,219,response to nutrient,BP
GO:1902532,4.795089473340498e-5,0.9999856947591247,18,567,negative regulation of intracellular signal transduction,BP
GO:0035234,4.800164454941704e-5,0.9999994585747125,3,7,ectopic germ cell programmed cell death,BP
GO:0019935,4.8558534700082196e-5,0.9999906258956713,11,217,cyclic-nucleotide-mediated signaling,BP
GO:0002768,4.8990844637898756e-5,0.9999873083239679,15,393,immune response-regulating cell surface receptor signaling pathway,BP
GO:0090407,4.901779444970018e-5,0.9999837214402453,21,697,organophosphate biosynthetic process,BP
GO:0001911,4.903960709965468e-5,0.9999984029766558,4,18,negative regulation of leukocyte mediated cytotoxicity,BP
GO:0019752,4.912137236757756e-5,0.9999806773843881,28,1084,carboxylic acid metabolic process,BP
GO:0098661,4.920713972369193e-5,0.999993551546594,8,111,inorganic anion transmembrane transport,BP
GO:0002028,4.9562610743816195e-5,0.9999946594003162,7,84,regulation of sodium ion transport,BP
GO:0051130,4.990166009876965e-5,0.9999793025220592,31,1254,positive regulation of cellular component organization,BP
GO:0060284,5.047702440172768e-5,0.9999809005071673,26,953,regulation of cell development,BP
GO:0048002,5.0593337086166876e-5,0.9999911599894376,10,186,antigen processing and presentation of peptide antigen,BP
GO:0031901,5.1532983060846865e-5,0.9999920506157692,9,147,early endosome membrane,CC
GO:0033267,5.190737533555809e-5,0.9999864888245463,15,383,axon part,CC
GO:0012507,5.2380699404174383e-5,0.9999956075742461,6,58,ER to Golgi transport vesicle membrane,CC
GO:0043406,5.260970070094617e-5,0.9999887956028447,12,259,positive regulation of MAP kinase activity,BP
GO:0019001,5.297934167265855e-5,0.9999861793674232,15,392,guanyl nucleotide binding,MF
GO:0032561,5.297934167265855e-5,0.9999861793674232,15,392,guanyl ribonucleotide binding,MF
GO:0015711,5.343316099468457e-5,0.9999846007828261,17,482,organic anion transport,BP
GO:0019722,5.378118120877776e-5,0.999989495947202,11,219,calcium-mediated signaling,BP
GO:0005789,5.405952498046363e-5,0.9999786164558043,28,1075,endoplasmic reticulum membrane,CC
GO:0048608,5.485769414869326e-5,0.9999848810795514,16,431,reproductive structure development,BP
GO:0043542,5.4934632234846236e-5,0.9999891946500176,11,273,endothelial cell migration,BP
GO:0035924,5.536117196276496e-5,0.9999952668448063,6,68,cellular response to vascular endothelial growth factor stimulus,BP
GO:0014065,5.5743348050856566e-5,0.9999913105446614,9,148,phosphatidylinositol 3-kinase signaling,BP
GO:0062013,5.5892401514760147e-5,0.9999912753627087,9,153,positive regulation of small molecule metabolic process,BP
GO:0072577,5.6339927412187394e-5,0.9999951756259953,6,66,endothelial cell apoptotic process,BP
GO:0000786,5.682452843417402e-5,0.9999936821510887,7,105,nucleosome,CC
GO:0018193,5.73765667958643e-5,0.9999760179612351,31,1257,peptidyl-amino acid modification,BP
GO:0098827,5.742964563579787e-5,0.9999772016434284,28,1079,endoplasmic reticulum subcompartment,CC
GO:0045824,5.760750747593406e-5,0.9999950796720849,6,59,negative regulation of innate immune response,BP
GO:0070838,5.814366879073445e-5,0.9999831252447878,17,485,divalent metal ion transport,BP
GO:0042133,5.8408733701373407e-5,0.9999908298660982,9,153,neurotransmitter metabolic process,BP
GO:0061458,5.8689944480452594e-5,0.9999837294314365,16,434,reproductive system development,BP
GO:0002726,5.873186470725476e-5,0.9999979762820921,4,19,positive regulation of T cell cytokine production,BP
GO:0007417,5.9447901800562e-5,0.9999768072360385,27,1005,central nervous system development,BP
GO:0022898,5.997281713680508e-5,0.9999870410119185,12,268,regulation of transmembrane transporter activity,BP
GO:0042107,6.0027767981521096e-5,0.9999918728498,8,124,cytokine metabolic process,BP
GO:0035580,6.171141889219721e-5,0.9999946465472275,6,62,specific granule lumen,CC
GO:2001056,6.281604716236144e-5,0.9999900494386991,9,150,positive regulation of cysteine-type endopeptidase activity,BP
GO:0043271,6.323799138362319e-5,0.9999899582106938,9,158,negative regulation of ion transport,BP
GO:1903725,6.416632443729602e-5,0.9999927784790567,7,88,regulation of phospholipid metabolic process,BP
GO:0015293,6.451565407225766e-5,0.999989757486449,9,144,symporter activity,MF
GO:0031667,6.511666626670391e-5,0.9999809171408043,17,499,response to nutrient levels,BP
GO:0007605,6.543282549206558e-5,0.9999895902967895,9,145,sensory perception of sound,BP
GO:1904951,6.617127805265179e-5,0.9999814535261855,16,453,positive regulation of establishment of protein localization,BP
GO:0017111,6.726178135815092e-5,0.9999752294736074,24,856,nucleoside-triphosphatase activity,MF
GO:0044085,6.73589391014839e-5,0.9999630189601435,62,3342,cellular component biogenesis,BP
GO:0002218,6.820374690986281e-5,0.999983891800662,13,318,activation of innate immune response,BP
GO:0032103,6.983652837524448e-5,0.9999834635048948,13,322,positive regulation of response to external stimulus,BP
GO:0034763,6.993650463140097e-5,0.999990307784452,8,129,negative regulation of transmembrane transport,BP
GO:0061024,7.009747834004642e-5,0.9999747448351173,23,823,membrane organization,BP
GO:0031668,7.078856520660798e-5,0.9999844348964965,12,267,cellular response to extracellular stimulus,BP
GO:2001236,7.153061714065056e-5,0.999988464737778,9,154,regulation of extrinsic apoptotic signaling pathway,BP
GO:0046394,7.168676012356006e-5,0.999979763043495,16,462,carboxylic acid biosynthetic process,BP
GO:0016053,7.311513896391959e-5,0.9999793240488714,16,463,organic acid biosynthetic process,BP
GO:0045665,7.312194449098463e-5,0.9999852042179488,11,226,negative regulation of neuron differentiation,BP
GO:2001280,7.483918239024973e-5,0.999998951675386,3,8,positive regulation of unsaturated fatty acid biosynthetic process,BP
GO:0006633,7.556113259943706e-5,0.9999877063701201,9,163,fatty acid biosynthetic process,BP
GO:0042175,7.563823921663143e-5,0.9999694751514135,28,1097,nuclear outer membrane-endoplasmic reticulum membrane network,CC
GO:0002685,7.589698281308017e-5,0.9999860553104019,10,195,regulation of leukocyte migration,BP
GO:0051252,7.669741973706778e-5,0.9999561219931967,70,3802,regulation of RNA metabolic process,BP
GO:0000187,7.739665173372305e-5,0.9999873909861857,9,153,activation of MAPK activity,BP
GO:1902476,7.754062337125211e-5,0.9999910037651097,7,88,chloride transmembrane transport,BP
GO:0045121,7.901826565711657e-5,0.9999810632047159,13,316,membrane raft,CC
GO:0004854,7.908810263513092e-5,1,2,2,xanthine dehydrogenase activity,MF
GO:0009115,7.908810263513092e-5,1,2,2,xanthine catabolic process,BP
GO:0016726,7.908810263513092e-5,1,2,2,"oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor",MF
GO:0016810,7.941332882139251e-5,0.9999888086479347,8,123,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",MF
GO:0030168,8.065172918033123e-5,0.9999867891034642,9,153,platelet activation,BP
GO:0042581,8.078845316228583e-5,0.999986748820524,9,159,specific granule,CC
GO:0045597,8.110117693360013e-5,0.9999683855732834,26,991,positive regulation of cell differentiation,BP
GO:0005635,8.13115649644324e-5,0.9999767941516041,16,463,nuclear envelope,CC
GO:0051048,8.170127266387632e-5,0.9999832386191222,11,239,negative regulation of secretion,BP
GO:0031406,8.185580177513972e-5,0.9999848275015678,10,192,carboxylic acid binding,MF
GO:0000904,8.186704292751975e-5,0.9999709808904935,22,746,cell morphogenesis involved in differentiation,BP
GO:0098857,8.207297893747426e-5,0.999980255098503,13,317,membrane microdomain,CC
GO:0046718,8.22759040910511e-5,0.9999883523561943,8,121,viral entry into host cell,BP
GO:1902105,8.265303615662619e-5,0.9999815179878262,12,272,regulation of leukocyte differentiation,BP
GO:0007219,8.322918169571196e-5,0.9999845396079999,10,193,Notch signaling pathway,BP
GO:0034702,8.427051848281113e-5,0.9999796919874115,13,301,ion channel complex,CC
GO:0051222,8.458774252524345e-5,0.9999769642756547,15,415,positive regulation of protein transport,BP
GO:0002221,8.671639581665034e-5,0.9999838007787635,10,198,pattern recognition receptor signaling pathway,BP
GO:0043270,8.784854258115195e-5,0.9999802255165514,12,274,positive regulation of ion transport,BP
GO:0006692,8.804136793250135e-5,0.9999941764451907,5,43,prostanoid metabolic process,BP
GO:0006693,8.804136793250135e-5,0.9999941764451907,5,43,prostaglandin metabolic process,BP
GO:0008544,8.933364252489403e-5,0.9999742959181358,16,463,epidermis development,BP
GO:0031175,9.063445182725318e-5,0.9999644263019665,26,978,neuron projection development,BP
GO:0002474,9.229258122884744e-5,0.9999889508518434,7,95,antigen processing and presentation of peptide antigen via MHC class I,BP
GO:0032409,9.471928968139116e-5,0.9999784936255353,12,283,regulation of transporter activity,BP
GO:0043550,9.479375561407427e-5,0.9999910891049422,6,64,regulation of lipid kinase activity,BP
GO:0002369,9.498411094302305e-5,0.9999936511177703,5,40,T cell cytokine production,BP
GO:0030728,9.543046931064571e-5,0.9999962083016812,4,21,ovulation,BP
GO:1903506,9.606685611547322e-5,0.999945494246978,66,3548,regulation of nucleic acid-templated transcription,BP
GO:0031620,9.650737193381544e-5,0.9999985258998966,3,8,regulation of fever generation,BP
GO:0048010,9.696436693231899e-5,0.9999882935439558,7,96,vascular endothelial growth factor receptor signaling pathway,BP
GO:0072172,9.821566471026329e-5,0.9999984908083509,3,8,mesonephric tubule formation,BP
GO:0035813,9.844605918593827e-5,0.9999960565717331,4,21,regulation of renal sodium excretion,BP
GO:0044815,9.88087879555242e-5,0.9999879613526389,7,113,DNA packaging complex,CC
GO:0001228,9.98656555477849e-5,0.9999710095055262,16,437,"DNA-binding transcription activator activity, RNA polymerase II-specific",MF
GO:0002687,1.0153072221285713e-4,0.9999851527433443,8,128,positive regulation of leukocyte migration,BP
GO:0006725,1.0194401847090707e-4,0.9999355684898746,102,6525,cellular aromatic compound metabolic process,BP
GO:0060047,1.0249340804143814e-4,0.9999765347246174,12,281,heart contraction,BP
GO:0045944,1.0314992225478438e-4,0.9999561331435034,30,1202,positive regulation of transcription by RNA polymerase II,BP
GO:2001141,1.032411956200505e-4,0.999941272574298,66,3557,regulation of RNA biosynthetic process,BP
GO:0070555,1.0351121614863754e-4,0.9999802207268645,10,207,response to interleukin-1,BP
GO:0031342,1.0569861888566383e-4,0.9999956575078331,4,22,negative regulation of cell killing,BP
GO:0005249,1.0582764525847644e-4,0.9999870962232975,7,87,voltage-gated potassium channel activity,MF
GO:0035455,1.0693288246865777e-4,0.9999955934473744,4,22,response to interferon-alpha,BP
GO:0071222,1.0705588581570072e-4,0.9999794658676615,10,204,cellular response to lipopolysaccharide,BP
GO:1902914,1.0874134848504127e-4,0.9999954468261206,4,24,regulation of protein polyubiquitination,BP
GO:0070820,1.090735936453221e-4,0.9999813709080646,9,163,tertiary granule,CC
GO:0044255,1.1024311260873163e-4,0.9999553104737449,27,1073,cellular lipid metabolic process,BP
GO:0050767,1.1091783538360175e-4,0.9999587716103396,23,823,regulation of neurogenesis,BP
GO:0045637,1.1123318024664278e-4,0.9999763404657067,11,251,regulation of myeloid cell differentiation,BP
GO:0035809,1.1168536739417664e-4,0.9999953449744805,4,22,regulation of urine volume,BP
GO:0045621,1.1222540102260762e-4,0.9999861387153569,7,94,positive regulation of lymphocyte differentiation,BP
GO:0015800,1.1276257861533929e-4,0.999989037700204,6,66,acidic amino acid transport,BP
GO:0044070,1.159253206673033e-4,0.9999855998909566,7,95,regulation of anion transport,BP
GO:0098589,1.1602772223649892e-4,0.9999710761848309,13,329,membrane region,CC
GO:0030666,1.182669613628882e-4,0.9999795786623146,9,164,endocytic vesicle membrane,CC
GO:0044297,1.1891049006029842e-4,0.9999618669949898,18,564,cell body,CC
GO:0034764,1.2008958232035835e-4,0.9999766375088859,10,204,positive regulation of transmembrane transport,BP
GO:0072330,1.2107780957860667e-4,0.9999696669994432,13,342,monocarboxylic acid biosynthetic process,BP
GO:0030020,1.2295626097895025e-4,0.999991295449132,5,41,extracellular matrix structural constituent conferring tensile strength,MF
GO:0043177,1.2373488691386913e-4,0.9999758396330108,10,204,organic acid binding,MF
GO:0005911,1.2399563533095056e-4,0.9999632901129932,16,460,cell-cell junction,CC
GO:1901568,1.2448229964933728e-4,0.9999783440986145,9,168,fatty acid derivative metabolic process,BP
GO:0030217,1.2486833397980641e-4,0.9999731112980776,11,240,T cell differentiation,BP
GO:0009892,1.2982535596042037e-4,0.9999277463921877,59,3526,negative regulation of metabolic process,BP
GO:1901653,1.324300260445412e-4,0.9999643927218442,14,387,cellular response to peptide,BP
GO:0030234,1.3333845382531738e-4,0.9999463450795274,26,1031,enzyme regulator activity,MF
GO:0042832,1.3526875040299624e-4,0.9999940031040361,4,24,defense response to protozoan,BP
GO:0015291,1.3845236987690933e-4,0.9999698385363333,11,237,secondary active transmembrane transporter activity,MF
GO:0003015,1.3887090508070174e-4,0.9999671293903859,12,291,heart process,BP
GO:0030425,1.3949679572519772e-4,0.999953040195066,19,620,dendrite,CC
GO:0048771,1.4040212446845911e-4,0.9999751382124658,9,179,tissue remodeling,BP
GO:0001501,1.4121202913736867e-4,0.9999558341200063,17,517,skeletal system development,BP
GO:0071219,1.4138772266076864e-4,0.9999719133022893,10,211,cellular response to molecule of bacterial origin,BP
GO:0031392,1.4141056817392402e-4,0.9999971987618658,3,12,regulation of prostaglandin biosynthetic process,BP
GO:0035812,1.4296355748387297e-4,0.9999936045728797,4,23,renal sodium excretion,BP
GO:0051701,1.4438680705132115e-4,0.9999712492684499,10,209,interaction with host,BP
GO:0008509,1.4549525849485593e-4,0.9999628918274176,13,326,anion transmembrane transporter activity,MF
GO:0097447,1.457819970523862e-4,0.9999507525382948,19,622,dendritic tree,CC
GO:0050670,1.46580554814627e-4,0.9999707611907444,10,208,regulation of lymphocyte proliferation,BP
GO:0030658,1.5034830726989986e-4,0.9999699288367961,10,204,transport vesicle membrane,CC
GO:0048729,1.5120005743426762e-4,0.9999471016869438,20,671,tissue morphogenesis,BP
GO:0014740,1.5212100948640834e-4,1,2,2,negative regulation of muscle hyperplasia,BP
GO:0032147,1.5222186261639424e-4,0.999960980655555,13,334,activation of protein kinase activity,BP
GO:0035850,1.523307855626423e-4,0.9999886445831131,5,44,epithelial cell differentiation involved in kidney development,BP
GO:0032944,1.5253359764691484e-4,0.9999694201673854,10,209,regulation of mononuclear cell proliferation,BP
GO:0051897,1.529529583532106e-4,0.9999726151745293,9,176,positive regulation of protein kinase B signaling,BP
GO:0038061,1.5384188640342618e-4,0.9999724079522629,9,183,NIK/NF-kappaB signaling,BP
GO:0150034,1.5403580488368017e-4,0.9999631408139887,12,286,distal axon,CC
GO:0005267,1.547197792118034e-4,0.999975970043332,8,123,potassium channel activity,MF
GO:0006809,1.5567675590208557e-4,0.9999838232950463,6,76,nitric oxide biosynthetic process,BP
GO:1904062,1.5607839806119428e-4,0.999959874039114,13,342,regulation of cation transmembrane transport,BP
GO:0016462,1.567508170861851e-4,0.999938899975396,24,905,pyrophosphatase activity,MF
GO:0043280,1.5708614404945552e-4,0.9999754854175723,8,133,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP
GO:0019219,1.5728292214168342e-4,0.9999066032864348,73,4120,regulation of nucleobase-containing compound metabolic process,BP
GO:0031225,1.5865564206253235e-4,0.9999714798864967,9,170,anchored component of membrane,CC
GO:0072183,1.631026889589966e-4,1,2,2,negative regulation of nephron tubule epithelial cell differentiation,BP
GO:0001562,1.6320449048781005e-4,0.999992361308994,4,25,response to protozoan,BP
GO:0030260,1.6422138819025708e-4,0.9999741979736528,8,134,entry into host cell,BP
GO:0044409,1.6422138819025708e-4,0.9999741979736528,8,134,entry into host,BP
GO:0051806,1.6422138819025708e-4,0.9999741979736528,8,134,entry into cell of other organism involved in symbiotic interaction,BP
GO:0051828,1.6422138819025708e-4,0.9999741979736528,8,134,entry into other organism involved in symbiotic interaction,BP
GO:0016817,1.6425309310053325e-4,0.9999357709858608,24,908,"hydrolase activity, acting on acid anhydrides",MF
GO:0016818,1.6425309310053325e-4,0.9999357709858608,24,908,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides",MF
GO:0035637,1.6660097308145044e-4,0.9999662515762217,10,204,multicellular organismal signaling,BP
GO:0043084,1.6703441899918513e-4,0.9999966631100947,3,10,penile erection,BP
GO:0042269,1.6874249708320055e-4,0.9999871400890585,5,44,regulation of natural killer cell mediated cytotoxicity,BP
GO:0044062,1.691598921257544e-4,0.9999920474369257,4,24,regulation of excretion,BP
GO:0044764,1.7012103693272646e-4,0.9999869324259626,5,48,multi-organism cellular process,BP
GO:0010876,1.7107048845646454e-4,0.9999528245799993,14,400,lipid localization,BP
GO:0033077,1.724203554057612e-4,0.9999818137501167,6,70,T cell differentiation in thymus,BP
GO:0043300,1.7348118873522934e-4,0.9999866369247203,5,47,regulation of leukocyte degranulation,BP
GO:0071347,1.7615534489404897e-4,0.9999678435451388,9,179,cellular response to interleukin-1,BP
GO:0050954,1.7678794848475263e-4,0.9999677804703194,9,165,sensory perception of mechanical stimulus,BP
GO:0002040,1.773934082698998e-4,0.9999715776829696,8,183,sprouting angiogenesis,BP
GO:0030857,1.777685667543182e-4,0.9999861957662388,5,49,negative regulation of epithelial cell differentiation,BP
GO:0006953,1.784990994757602e-4,0.9999861653491507,5,47,acute-phase response,BP
GO:0030139,1.7853221640209646e-4,0.9999565493238557,12,301,endocytic vesicle,CC
GO:0006355,1.7936906816063417e-4,0.9998966125367554,64,3488,"regulation of transcription, DNA-templated",BP
GO:0001516,1.801301554208303e-4,0.9999912380154184,4,28,prostaglandin biosynthetic process,BP
GO:0046457,1.801301554208303e-4,0.9999912380154184,4,28,prostanoid biosynthetic process,BP
GO:1901615,1.8200654900863572e-4,0.9999418098850301,17,535,organic hydroxy compound metabolic process,BP
GO:0032677,1.8207630457533428e-4,0.9999805470477064,6,74,regulation of interleukin-8 production,BP
GO:1903508,1.8327281668334004e-4,0.9999127865916416,36,1617,positive regulation of nucleic acid-templated transcription,BP
GO:1902680,1.850817197578871e-4,0.9999118797295942,36,1618,positive regulation of RNA biosynthetic process,BP
GO:0071639,1.851762756948836e-4,0.9999959779760138,3,12,positive regulation of monocyte chemotactic protein-1 production,BP
GO:0039528,1.8563495195152415e-4,0.9999909334880452,4,27,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP
GO:0015108,1.8605053315533476e-4,0.9999749843946698,7,100,chloride transmembrane transporter activity,MF
GO:0071229,1.8840995815072305e-4,0.9999612239992554,10,209,cellular response to acid chemical,BP
GO:0043303,1.9460351319172022e-4,0.99998461058652,5,48,mast cell degranulation,BP
GO:0006816,1.9867769787674678e-4,0.9999414339210813,15,436,calcium ion transport,BP
GO:0010950,1.986813390163171e-4,0.9999631385734564,9,179,positive regulation of endopeptidase activity,BP
GO:0009056,1.994004030780554e-4,0.9998927122436738,50,2617,catabolic process,BP
GO:1904019,2.0129823168887632e-4,0.9999724696321085,7,112,epithelial cell apoptotic process,BP
GO:1904645,2.04935632232169e-4,0.9999834898811039,5,54,response to amyloid-beta,BP
GO:0090037,2.0665637954130233e-4,0.999995559625093,3,10,positive regulation of protein kinase C signaling,BP
GO:0016567,2.0926167340238054e-4,0.9999206335044223,22,824,protein ubiquitination,BP
GO:0002715,2.1143142620755543e-4,0.9999830259173487,5,46,regulation of natural killer cell mediated immunity,BP
GO:0018195,2.1197970291378807e-4,0.9999892787720355,4,27,peptidyl-arginine modification,BP
GO:0045776,2.132430567989835e-4,0.9999828232252871,5,47,negative regulation of blood pressure,BP
GO:0002279,2.172384784248614e-4,0.9999823818761694,5,49,mast cell activation involved in immune response,BP
GO:0005769,2.186777442974428e-4,0.9999417798248463,13,348,early endosome,CC
GO:0048483,2.1889483559632165e-4,0.9999823214759506,5,45,autonomic nervous system development,BP
GO:0003725,2.193462551399239e-4,0.999975723714068,6,75,double-stranded RNA binding,MF
GO:0016702,2.2067962470510968e-4,0.9999887198291116,4,27,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",MF
GO:0046209,2.2347068686233657e-4,0.999975095576773,6,81,nitric oxide metabolic process,BP
GO:0042035,2.2447772885078598e-4,0.9999687259928635,7,114,regulation of cytokine biosynthetic process,BP
GO:0000977,2.2925781210863857e-4,0.9999125109245418,22,786,RNA polymerase II regulatory region sequence-specific DNA binding,MF
GO:0061061,2.30283285125933e-4,0.9999192705576112,19,672,muscle structure development,BP
GO:0072676,2.3175039900850345e-4,0.9999675922944266,7,109,lymphocyte migration,BP
GO:0015294,2.3412353425243286e-4,0.999967283980294,7,102,solute:cation symporter activity,MF
GO:0002448,2.3519194340477888e-4,0.9999805688329114,5,50,mast cell mediated immunity,BP
GO:0002704,2.374755883774719e-4,0.999980364411417,5,49,negative regulation of leukocyte mediated immunity,BP
GO:0001894,2.3865001988901315e-4,0.9999493404365717,10,223,tissue homeostasis,BP
GO:2000341,2.3887388174951676e-4,0.9999943391893622,3,12,regulation of chemokine (C-X-C motif) ligand 2 production,BP
GO:0033089,2.391235752963442e-4,0.9999944515372327,3,11,positive regulation of T cell differentiation in thymus,BP
GO:0006869,2.4161463345462114e-4,0.9999349575355407,13,365,lipid transport,BP
GO:0035094,2.4208283860541017e-4,0.999979899661636,5,49,response to nicotine,BP
GO:0015370,2.4636712056190735e-4,0.9999721897197595,6,72,solute:sodium symporter activity,MF
GO:0016813,2.4865676460495285e-4,0.9999941524715679,3,11,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines",MF
GO:0019216,2.518765013944692e-4,0.9999278298900948,14,411,regulation of lipid metabolic process,BP
GO:0003677,2.525822198013959e-4,0.9998635741461432,49,2497,DNA binding,MF
GO:0001012,2.5408507174258933e-4,0.9999023012485077,22,792,RNA polymerase II regulatory region DNA binding,MF
GO:0030660,2.553225323880108e-4,0.9999637094846918,7,110,Golgi-associated vesicle membrane,CC
GO:0050729,2.5765695316313006e-4,0.9999565711732198,8,152,positive regulation of inflammatory response,BP
GO:0016701,2.5899486796653065e-4,0.9999861369555652,4,28,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen",MF
GO:0048015,2.635100713217727e-4,0.9999491896662923,9,181,phosphatidylinositol-mediated signaling,BP
GO:0016323,2.635396964283277e-4,0.9999433883516066,10,217,basolateral plasma membrane,CC
GO:0002730,2.660827548902282e-4,0.999993595560681,3,11,regulation of dendritic cell cytokine production,BP
GO:0005254,2.6774949704005935e-4,0.999969242074654,6,75,chloride channel activity,MF
GO:0031252,2.689756170588083e-4,0.9999224474183565,14,404,cell leading edge,CC
GO:2001057,2.7283757206114894e-4,0.9999683907933775,6,84,reactive nitrogen species metabolic process,BP
GO:0032675,2.7404050078215167e-4,0.9999533837973626,8,152,regulation of interleukin-6 production,BP
GO:1901224,2.745285870671676e-4,0.9999682770891819,6,77,positive regulation of NIK/NF-kappaB signaling,BP
GO:2001279,2.7475901736233245e-4,0.999992945660884,3,14,regulation of unsaturated fatty acid biosynthetic process,BP
GO:0030098,2.748841368315103e-4,0.999925039866138,13,353,lymphocyte differentiation,BP
GO:2000649,2.7568905881941713e-4,0.9999763924120306,5,51,regulation of sodium ion transmembrane transporter activity,BP
GO:0006865,2.762004713968356e-4,0.999953031341122,8,144,amino acid transport,BP
GO:1902475,2.8098511349247164e-4,0.999975838891035,5,51,L-alpha-amino acid transmembrane transport,BP
GO:0043933,2.813731076279117e-4,0.9998525180335148,44,2277,protein-containing complex subunit organization,BP
GO:0098586,2.8312654790814146e-4,0.9999755049791087,5,55,cellular response to virus,BP
GO:1901222,2.8485543676790514e-4,0.9999586877651919,7,117,regulation of NIK/NF-kappaB signaling,BP
GO:0060341,2.875151059208142e-4,0.9998856820270442,23,903,regulation of cellular localization,BP
GO:0040008,2.8832255027535586e-4,0.9998970761663943,19,677,regulation of growth,BP
GO:0046110,2.9344233066920956e-4,0.9999990250884347,2,3,xanthine metabolic process,BP
GO:1990266,2.93444179983993e-4,0.9999572322683739,7,117,neutrophil migration,BP
GO:0048017,2.9501486053697275e-4,0.9999422096340013,9,184,inositol lipid-mediated signaling,BP
GO:0097659,2.95898358337931e-4,0.9998246161811143,66,3698,nucleic acid-templated transcription,BP
GO:0032446,2.9622578453119305e-4,0.9998819635042608,23,907,protein modification by small protein conjugation,BP
GO:0045893,3.0042032652673005e-4,0.999856474117665,34,1532,"positive regulation of transcription, DNA-templated",BP
GO:0030449,3.005447663838268e-4,0.9999736849103871,5,54,regulation of complement activation,BP
GO:0009743,3.0069485057445983e-4,0.9999342438315563,10,230,response to carbohydrate,BP
GO:0060759,3.0489774947342044e-4,0.9999399522283846,9,191,regulation of response to cytokine stimulus,BP
GO:0030100,3.103139720354887e-4,0.999925497836544,11,280,regulation of endocytosis,BP
GO:0032642,3.11755240559084e-4,0.9999630047517778,6,82,regulation of chemokine production,BP
GO:0018108,3.1358431050340803e-4,0.9999132647363349,13,363,peptidyl-tyrosine phosphorylation,BP
GO:0002477,3.1629843459804127e-4,0.9999989085762784,2,3,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP
GO:0032609,3.1633936566641355e-4,0.9999533842096502,7,112,interferon-gamma production,BP
GO:0065003,3.1656731293533945e-4,0.9998400641689135,39,1957,protein-containing complex assembly,BP
GO:0031893,3.171210076818788e-4,0.9999989043010825,2,3,vasopressin receptor binding,MF
GO:0048659,3.172938246545701e-4,0.9999446616113746,8,172,smooth muscle cell proliferation,BP
GO:0045744,3.1763221609448707e-4,0.9999718816484187,5,53,negative regulation of G protein-coupled receptor signaling pathway,BP
GO:0072088,3.1806767701367294e-4,0.9999622391258904,6,76,nephron epithelium morphogenesis,BP
GO:0002551,3.220844051621605e-4,0.9999915428087705,3,12,mast cell chemotaxis,BP
GO:0097531,3.220844051621605e-4,0.9999915428087705,3,12,mast cell migration,BP
GO:0030308,3.2321559183991677e-4,0.9999358738198315,9,186,negative regulation of cell growth,BP
GO:2000351,3.237694701972297e-4,0.9999710206664523,5,60,regulation of endothelial cell apoptotic process,BP
GO:2000257,3.269035200889725e-4,0.999970815866284,5,55,regulation of protein activation cascade,BP
GO:0098810,3.277173054530635e-4,0.9999814025231073,4,27,neurotransmitter reuptake,BP
GO:0070206,3.2905758827944773e-4,0.9999706122344911,5,54,protein trimerization,BP
GO:0046456,3.3342692612022e-4,0.9999700744052424,5,56,icosanoid biosynthetic process,BP
GO:0032774,3.3386286140757264e-4,0.9998011992253292,66,3715,RNA biosynthetic process,BP
GO:0018212,3.369691517750525e-4,0.9999060795939142,13,366,peptidyl-tyrosine modification,BP
GO:0045747,3.4765732586217223e-4,0.99996857536629,5,54,positive regulation of Notch signaling pathway,BP
GO:0006351,3.4856207579194636e-4,0.9997928216637663,65,3650,"transcription, DNA-templated",BP
GO:0004869,3.523194967441206e-4,0.9999679640418438,5,57,cysteine-type endopeptidase inhibitor activity,MF
GO:0042310,3.535443578806242e-4,0.9999571837633209,6,76,vasoconstriction,BP
GO:0071216,3.5450085896824576e-4,0.9999208108199418,10,235,cellular response to biotic stimulus,BP
GO:0072178,3.5673488366577173e-4,0.9999902979599172,3,12,nephric duct morphogenesis,BP
GO:0072028,3.568533225806177e-4,0.999956656593055,6,78,nephron morphogenesis,BP
GO:0010557,3.623010185383041e-4,0.9998157145986029,39,1877,positive regulation of macromolecule biosynthetic process,BP
GO:0032647,3.6283229288053997e-4,0.9999787651191393,4,28,regulation of interferon-alpha production,BP
GO:0031344,3.630399739765291e-4,0.9998679521518379,19,682,regulation of cell projection organization,BP
GO:0070268,3.672227090685144e-4,0.9999445264509446,7,112,cornification,BP
GO:0046677,3.678972855510082e-4,0.9999029066151609,12,328,response to antibiotic,BP
GO:0042089,3.6812181989080635e-4,0.9999442020367632,7,123,cytokine biosynthetic process,BP
GO:0015103,3.6892660426386453e-4,0.9999344594153228,8,146,inorganic anion transmembrane transporter activity,MF
GO:0007548,3.70028339746093e-4,0.9999093509970183,11,270,sex differentiation,BP
GO:0005080,3.720620932324708e-4,0.9999659031002746,5,53,protein kinase C binding,MF
GO:0003006,3.7374080505552773e-4,0.9998637537209132,19,674,developmental process involved in reproduction,BP
GO:0010634,3.801135625839283e-4,0.9999318945864046,8,171,positive regulation of epithelial cell migration,BP
GO:0030856,3.8012291384147904e-4,0.9999320459426075,8,156,regulation of epithelial cell differentiation,BP
GO:0061082,3.8228569268235126e-4,0.9999771594268644,4,30,myeloid leukocyte cytokine production,BP
GO:0035025,3.8276013208394865e-4,0.99997719815066,4,29,positive regulation of Rho protein signal transduction,BP
GO:0005525,3.8384337816377344e-4,0.9998915165991142,13,371,GTP binding,MF
GO:0043331,3.845276309249234e-4,0.9999645051283642,5,53,response to dsRNA,BP
GO:0042742,3.8595650566757597e-4,0.9999126841380745,10,260,defense response to bacterium,BP
GO:0060205,3.9692298036735394e-4,0.9998943062790523,12,338,cytoplasmic vesicle lumen,CC
GO:0061005,4.007322904282727e-4,0.9999626320388939,5,54,cell differentiation involved in kidney development,BP
GO:0023061,4.018973570902133e-4,0.9998732735465933,15,463,signal release,BP
GO:0031983,4.0925825724928255e-4,0.9998906432423718,12,339,vesicle lumen,CC
GO:0042129,4.1194788645756026e-4,0.9999254596075267,8,156,regulation of T cell proliferation,BP
GO:0045582,4.122787942908368e-4,0.9999484047367566,6,83,positive regulation of T cell differentiation,BP
GO:0003333,4.1273693941442757e-4,0.9999483112494643,6,84,amino acid transmembrane transport,BP
GO:0010952,4.141149016113609e-4,0.999914873210322,9,198,positive regulation of peptidase activity,BP
GO:0032635,4.1776616224362774e-4,0.9999241863658902,8,161,interleukin-6 production,BP
GO:0044431,4.183655850169206e-4,0.9998253911769472,24,974,Golgi apparatus part,CC
GO:0006139,4.1888401273128874e-4,0.9997261356611331,96,6320,nucleobase-containing compound metabolic process,BP
GO:0043304,4.193971851931635e-4,0.9999741663041987,4,32,regulation of mast cell degranulation,BP
GO:0032550,4.200262909237165e-4,0.9998801364643638,13,375,purine ribonucleoside binding,MF
GO:0072567,4.2077359462365494e-4,0.9999874926921658,3,14,chemokine (C-X-C motif) ligand 2 production,BP
GO:0009790,4.2662488342067625e-4,0.9998181242712779,25,1019,embryo development,BP
GO:0031650,4.272360562482957e-4,0.9999874181119304,3,13,regulation of heat generation,BP
GO:0060249,4.2731963721543087e-4,0.9998708383845109,14,436,anatomical structure homeostasis,BP
GO:0070647,4.277823834385302e-4,0.9998141244219995,26,1109,protein modification by small protein conjugation or removal,BP
GO:0010977,4.337119144985222e-4,0.9999209094963565,8,156,negative regulation of neuron projection development,BP
GO:0034641,4.350671272436482e-4,0.9997103632130725,105,7065,cellular nitrogen compound metabolic process,BP
GO:0045935,4.3670532720867445e-4,0.9997756792290284,39,1896,positive regulation of nucleobase-containing compound metabolic process,BP
GO:0005283,4.3894950823240034e-4,0.9999867609207113,3,14,amino acid:sodium symporter activity,MF
GO:0005164,4.3919017471438543e-4,0.9999726903193592,4,31,tumor necrosis factor receptor binding,MF
GO:0006644,4.4366862747652054e-4,0.9998654086322074,14,431,phospholipid metabolic process,BP
GO:0046483,4.4592462965132755e-4,0.9997067108065772,98,6480,heterocycle metabolic process,BP
GO:2000778,4.4629072940367023e-4,0.9999720512428356,4,32,positive regulation of interleukin-6 secretion,BP
GO:0051641,4.483535479584621e-4,0.9997454241016315,53,2919,cellular localization,BP
GO:0072182,4.494741523296718e-4,0.9999865296216808,3,13,regulation of nephron tubule epithelial cell differentiation,BP
GO:0071417,4.4952536919412605e-4,0.9998443814073597,17,586,cellular response to organonitrogen compound,BP
GO:0001883,4.535828468373239e-4,0.9998694862313096,13,378,purine nucleoside binding,MF
GO:0051254,4.5809883515940224e-4,0.9997708721219188,36,1702,positive regulation of RNA metabolic process,BP
GO:0008625,4.6332336870931945e-4,0.9999406094025858,6,87,extrinsic apoptotic signaling pathway via death domain receptors,BP
GO:0032607,4.634811378468752e-4,0.9999708519962826,4,30,interferon-alpha production,BP
GO:0032549,4.660897249199634e-4,0.999865494434218,13,379,ribonucleoside binding,MF
GO:0032787,4.782499197829456e-4,0.99982757950033,18,651,monocarboxylic acid metabolic process,BP
GO:0033006,4.80068277021342e-4,0.99996926496223415,4,33,regulation of mast cell activation involved in immune response,BP
GO:0032602,4.801737923976717e-4,0.9999379768802954,6,89,chemokine production,BP
GO:0090183,4.896719472836903e-4,0.9999521821048711,5,56,regulation of kidney development,BP
GO:0098889,4.902529843298491e-4,0.9999366313895183,6,82,intrinsic component of presynaptic membrane,CC
GO:0006957,4.920715058769299e-4,0.9999842058428905,3,16,"complement activation, alternative pathway",BP
GO:0006919,4.931554394280894e-4,0.9999360326838223,6,87,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP
GO:0008282,4.942862261339041e-4,0.9999978622800777,2,3,inward rectifying potassium channel,CC
GO:0034343,4.952204646550084e-4,0.99999785619003,2,3,type III interferon production,BP
GO:0034344,4.952204646550084e-4,0.99999785619003,2,3,regulation of type III interferon production,BP
GO:0010556,4.956251376763444e-4,0.9996958325555256,70,4120,regulation of macromolecule biosynthetic process,BP
GO:0050679,5.000608463565424e-4,0.9998944009853262,9,206,positive regulation of epithelial cell proliferation,BP
GO:0030030,5.028999184019487e-4,0.9997554232744902,33,1536,cell projection organization,BP
GO:0044212,5.085553656911743e-4,0.9997848341101677,24,952,transcription regulatory region DNA binding,MF
GO:0051781,5.092051489484159e-4,0.99993354787952,6,87,positive regulation of cell division,BP
GO:0043552,5.10247453632494e-4,0.9999668845370248,4,32,positive regulation of phosphatidylinositol 3-kinase activity,BP
GO:0010942,5.125573159336388e-4,0.9998080926267242,19,732,positive regulation of cell death,BP
GO:0000976,5.155021241940167e-4,0.9997910198230103,22,837,transcription regulatory region sequence-specific DNA binding,MF
GO:0001067,5.167978994368835e-4,0.9997810946447833,24,953,regulatory region nucleic acid binding,MF
GO:0097756,5.191754297595122e-4,0.99993209106635494,6,84,negative regulation of blood vessel diameter,BP
GO:0050662,5.285531346566091e-4,0.9998647097999241,11,291,coenzyme binding,MF
GO:0032589,5.293978948779369e-4,0.9999473545794555,5,57,neuron projection membrane,CC
GO:0045953,5.295182622331385e-4,0.9999829615309922,3,14,negative regulation of natural killer cell mediated cytotoxicity,BP
GO:0035810,5.297042767181958e-4,0.9999829534776968,3,14,positive regulation of urine volume,BP
GO:0014066,5.333865704622851e-4,0.9999139503971978,7,124,regulation of phosphatidylinositol 3-kinase signaling,BP
GO:0010632,5.378467081853734e-4,0.9998728017408164,10,292,regulation of epithelial cell migration,BP
GO:0000139,5.407987235444506e-4,0.9997907884914221,20,753,Golgi membrane,CC
GO:0045926,5.433768653455269e-4,0.9998716660474714,10,249,negative regulation of growth,BP
GO:0031214,5.46606319148337e-4,0.9998966840919231,8,161,biomineral tissue development,BP
GO:0032890,5.483131019367633e-4,0.9999449488778132,5,59,regulation of organic acid transport,BP
GO:0043065,5.483762508148415e-4,0.99979989821905,18,675,positive regulation of apoptotic process,BP
GO:0051955,5.484960546233433e-4,0.9999636127732046,4,33,regulation of amino acid transport,BP
GO:0005773,5.494670467343566e-4,0.9997871195052637,20,771,vacuole,CC
GO:1903305,5.49616557392427e-4,0.999896044314118,8,160,regulation of regulated secretory pathway,BP
GO:0010817,5.49674052535421e-4,0.9998135380387637,16,531,regulation of hormone levels,BP
GO:0001882,5.545297844972831e-4,0.9998369380209652,13,386,nucleoside binding,MF
GO:0010605,5.552108621608576e-4,0.9996816205643285,53,3289,negative regulation of macromolecule metabolic process,BP
GO:0030134,5.598902900495868e-4,0.9999255375581465,6,89,COPII-coated ER to Golgi transport vesicle,CC
GO:1901135,5.600394935379824e-4,0.9997438117694091,28,1262,carbohydrate derivative metabolic process,BP
GO:0046629,5.606056189954074e-4,0.9999816021157241,3,14,gamma-delta T cell activation,BP
GO:0032352,5.846589441575028e-4,0.9999802916210893,3,15,positive regulation of hormone metabolic process,BP
GO:0098742,0.00059063434836860375,0.9998469399245603,11,274,cell-cell adhesion via plasma-membrane adhesion molecules,BP
GO:0034405,5.907123690994199e-4,0.9999596672069567,4,37,response to fluid shear stress,BP
GO:0043068,6.077511078163979e-4,0.9997762373329193,18,683,positive regulation of programmed cell death,BP
GO:0071407,6.080303040045034e-4,0.9997917533331897,16,541,cellular response to organic cyclic compound,BP
GO:0030133,6.094056289607866e-4,0.9998189602950521,13,389,transport vesicle,CC
GO:0002717,6.107063996589303e-4,0.9999583046513844,4,33,positive regulation of natural killer cell mediated immunity,BP
GO:0045576,6.121553905101233e-4,0.9999369164740406,5,61,mast cell activation,BP
GO:0062012,6.124776342778542e-4,0.9998078726789273,14,459,regulation of small molecule metabolic process,BP
GO:0044325,6.156073418799866e-4,0.9998982541914653,7,124,ion channel binding,MF
GO:0002701,6.16330480956228e-4,0.9999576160068904,4,35,negative regulation of production of molecular mediator of immune response,BP
GO:0016814,6.176272240106659e-4,0.9999576007225399,4,34,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines",MF
GO:0048598,6.399975702382488e-4,0.999771354246215,17,587,embryonic morphogenesis,BP
GO:0001885,6.429428554985495e-4,0.9999331324384358,5,59,endothelial cell development,BP
GO:0016838,6.465628983789164e-4,0.9999954764358331,2,4,"carbon-oxygen lyase activity, acting on phosphates",MF
GO:1902305,6.465932681513061e-4,0.9999325544590022,5,61,regulation of sodium ion transmembrane transport,BP
GO:0002753,6.622309178279066e-4,0.9999304466973599,5,63,cytoplasmic pattern recognition receptor signaling pathway,BP
GO:0051345,6.626338883617159e-4,0.9997393685565975,20,773,positive regulation of hydrolase activity,BP
GO:0072160,6.631668404307736e-4,0.9999766491049605,3,15,nephron tubule epithelial cell differentiation,BP
GO:0002716,6.65304837041656e-4,0.9999765476986634,3,15,negative regulation of natural killer cell mediated immunity,BP
GO:0042267,6.668733181248925e-4,0.9999300189063984,5,60,natural killer cell mediated cytotoxicity,BP
GO:0005253,6.724366454394357e-4,0.9999073864730332,6,89,anion channel activity,MF
GO:0120036,6.774907908735907e-4,0.9996686147693885,32,1499,plasma membrane bounded cell projection organization,BP
GO:0002830,6.813799446563934e-4,0.999975525893193,3,16,positive regulation of type 2 immune response,BP
GO:0055086,6.843702944922753e-4,0.9997300420467696,20,798,nucleobase-containing small molecule metabolic process,BP
GO:0009112,6.843703834349293e-4,0.9999514929820956,4,36,nucleobase metabolic process,BP
GO:0042391,6.868229245443496e-4,0.9997821464616202,14,436,regulation of membrane potential,BP
GO:0032695,6.900748588484919e-4,0.9999751045026604,3,16,negative regulation of interleukin-12 production,BP
GO:0042157,6.941587710659908e-4,0.9998827296974442,7,131,lipoprotein metabolic process,BP
GO:0005314,6.971218085850535e-4,0.9999949330279221,2,4,high-affinity glutamate transmembrane transporter activity,MF
GO:0015501,6.971218085850535e-4,0.9999949330279221,2,4,glutamate:sodium symporter activity,MF
GO:0003690,7.03672051573276e-4,0.9996952049963632,24,978,double-stranded DNA binding,MF
GO:0050764,7.088177455501813e-4,0.9999010458432507,6,98,regulation of phagocytosis,BP
GO:0032849,7.123463233812354e-4,0.9999947653546627,2,4,positive regulation of cellular pH reduction,BP
GO:0045917,7.168715969690101e-4,0.9999933257589422,2,6,positive regulation of complement activation,BP
GO:2000259,7.168715969690101e-4,0.9999933257589422,2,6,positive regulation of protein activation cascade,BP
GO:0001766,7.257087932492712e-4,0.9999946166758749,2,4,membrane raft polarization,BP
GO:0014805,7.257481500091171e-4,0.9999937507804915,2,5,smooth muscle adaptation,BP
GO:0098858,7.28018687005683e-4,0.9998379324296913,9,209,actin-based cell projection,CC
GO:0033002,7.30865511253092e-4,0.999836788628328,9,240,muscle cell proliferation,BP
GO:0003373,7.363700089556754e-4,0.9999944970473125,2,4,dynamin family protein polymerization involved in membrane fission,BP
GO:0003374,7.363700089556754e-4,0.9999944970473125,2,4,dynamin family protein polymerization involved in mitochondrial fission,BP
GO:0019229,7.474793286806517e-4,0.999919685729911,5,58,regulation of vasoconstriction,BP
GO:0060355,7.493610390971456e-4,0.9999943500795314,2,4,positive regulation of cell adhesion molecule production,BP
GO:0043025,7.577713470834707e-4,0.9997456796227753,15,497,neuronal cell body,CC
GO:0005764,7.591233467040782e-4,0.9997150869224739,18,677,lysosome,CC
GO:0005229,7.591944034660716e-4,0.9999716896577991,3,16,intracellular calcium activated chloride channel activity,MF
GO:0061778,7.591944034660716e-4,0.9999716896577991,3,16,intracellular chloride channel activity,MF
GO:0097060,7.683594221571548e-4,0.9997534836392257,14,432,synaptic membrane,CC
GO:0000323,7.689277363391188e-4,0.9997110802058626,18,678,lytic vacuole,CC
GO:0001666,7.69582502209712e-4,0.9997789388700387,12,359,response to hypoxia,BP
GO:0051302,7.745354387816701e-4,0.9998454299568892,8,168,regulation of cell division,BP
GO:0071605,7.745923854869081e-4,0.9999704134730587,3,18,monocyte chemotactic protein-1 production,BP
GO:0071637,7.745923854869081e-4,0.9999704134730587,3,18,regulation of monocyte chemotactic protein-1 production,BP
GO:0051926,7.774588916699088e-4,0.9999151393418091,5,67,negative regulation of calcium ion transport,BP
GO:0009314,7.781852012763873e-4,0.9997498852742999,14,449,response to radiation,BP
GO:0030949,7.790339870157349e-4,0.999969974673003,3,19,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP
GO:0006910,7.828976917691401e-4,0.9999704927658629,3,16,"phagocytosis, recognition",BP
GO:0032755,7.829974819162191e-4,0.9998886608010068,6,96,positive regulation of interleukin-6 production,BP
GO:0098801,7.916420568638311e-4,0.9999417776527258,4,35,regulation of renal system process,BP
GO:0043114,7.927643703776528e-4,0.9999414281653896,4,37,regulation of vascular permeability,BP
GO:0014738,7.932345611080591e-4,0.999993844160699,2,4,regulation of muscle hyperplasia,BP
GO:0090218,7.937130468261475e-4,0.9999414582081196,4,36,positive regulation of lipid kinase activity,BP
GO:0120035,8.096281953372951e-4,0.9996944392944754,18,672,regulation of plasma membrane bounded cell projection organization,BP
GO:1901570,8.193898916420041e-4,0.9998823017130165,6,100,fatty acid derivative biosynthetic process,BP
GO:0031589,8.201816155407222e-4,0.999762731302516,12,353,cell-substrate adhesion,BP
GO:0055037,8.210990250332822e-4,0.9998345686989634,8,172,recycling endosome,CC
GO:0016491,8.310195225860758e-4,0.9996759922758058,19,744,oxidoreductase activity,MF
GO:0008289,8.362824734547943e-4,0.999673812283253,19,732,lipid binding,MF
GO:0090036,8.365341163076081e-4,0.9999677376265087,3,16,regulation of protein kinase C signaling,BP
GO:0097067,8.422710082025996e-4,0.9999674391812788,3,16,cellular response to thyroid hormone stimulus,BP
GO:0050806,8.468713554429255e-4,0.9998286300491154,8,169,positive regulation of synaptic transmission,BP
GO:0045862,8.494861070904263e-4,0.9997531555749218,12,364,positive regulation of proteolysis,BP
GO:2000112,8.496981233044581e-4,0.9994726620970259,67,3981,regulation of cellular macromolecule biosynthetic process,BP
GO:0010919,8.552784054553844e-4,0.9999667598676772,3,16,regulation of inositol phosphate biosynthetic process,BP
GO:0072176,8.571781368347303e-4,0.9999666603486439,3,16,nephric duct development,BP
GO:0072080,8.617715849688416e-4,0.9998753166820884,6,93,nephron tubule development,BP
GO:0031143,8.640023227208961e-4,0.999965994844332,3,17,pseudopodium,CC
GO:0032740,8.695811333972795e-4,0.999965698679108,3,17,positive regulation of interleukin-17 production,BP
GO:0006835,8.708280043136177e-4,0.999873611789554,6,96,dicarboxylic acid transport,BP
GO:0002429,8.724254959644128e-4,0.9997457487569487,12,360,immune response-activating cell surface receptor signaling pathway,BP
GO:0015807,8.781019536118951e-4,0.9999016515697434,5,65,L-amino acid transport,BP
GO:0051933,8.854184887755205e-4,0.9999927344415305,2,4,amino acid neurotransmitter reuptake,BP
GO:0051935,8.854184887755205e-4,0.9999927344415305,2,4,glutamate reuptake,BP
GO:0034766,8.859825019961659e-4,0.9998706432076044,6,104,negative regulation of ion transmembrane transport,BP
GO:0007423,8.87537476927266e-4,0.9996849704877618,16,548,sensory organ development,BP
GO:0032587,8.887574047968529e-4,0.9998705017063376,6,96,ruffle membrane,CC
GO:0030593,8.914885350065408e-4,0.9998697236411052,6,103,neutrophil chemotaxis,BP
GO:0002228,8.935850313516576e-4,0.9998995980867379,5,64,natural killer cell mediated immunity,BP
GO:0015893,8.969452110884958e-4,0.9997942630141461,9,214,drug transport,BP
GO:0097530,9.045119904913267e-4,0.9998398612533482,7,140,granulocyte migration,BP
GO:0002707,9.161836352767379e-4,0.9999294850622624,4,38,negative regulation of lymphocyte mediated immunity,BP
GO:0070851,9.188168868549989e-4,0.9998370782494389,7,134,growth factor receptor binding,MF
GO:0034774,9.22862956330783e-4,0.9997468588296109,11,321,secretory granule lumen,CC
GO:0045936,9.230577539599735e-4,0.9996709144454429,16,586,negative regulation of phosphate metabolic process,BP
GO:0072180,9.246078223284473e-4,0.9999922441310884,2,4,mesonephric duct morphogenesis,BP
GO:0017157,9.322928253725471e-4,0.9997849224249632,9,217,regulation of exocytosis,BP
GO:0060993,9.405673790275047e-4,0.999861546696491,6,94,kidney morphogenesis,BP
GO:0010563,9.419134304664799e-4,0.9996635402395033,16,587,negative regulation of phosphorus metabolic process,BP
GO:1990523,9.515527083615176e-4,0.9999919007767208,2,4,bone regeneration,BP
GO:0035549,9.556424223080608e-4,0.999991848223166,2,4,positive regulation of interferon-beta secretion,BP
GO:0071542,9.641212901569579e-4,0.999924910708042,4,37,dopaminergic neuron differentiation,BP
GO:0015272,9.653107440019751e-4,0.9999917235265783,2,4,ATP-activated inward rectifier potassium channel activity,MF
GO:0061326,9.705585976455045e-4,0.9998562092782476,6,95,renal tubule development,BP
GO:0006333,9.707993801206128e-4,0.9997988730143542,8,189,chromatin assembly or disassembly,BP
GO:0060191,9.809599025675552e-4,0.9998541644494787,6,99,regulation of lipase activity,BP
GO:0098794,9.832760766655918e-4,0.9996345988801648,17,614,postsynapse,CC
GO:0050766,9.89586027008987e-4,0.9998857893979438,5,70,positive regulation of phagocytosis,BP
GO:0036293,0.0010116951154678787,0.9996999598770466,12,370,response to decreased oxygen levels,BP
GO:0005416,0.0010127982596215494,0.9999575386947054,3,18,amino acid:cation symporter activity,MF
GO:0090596,0.0010140873908272671,0.9997400770244889,10,256,sensory organ morphogenesis,BP
GO:0044248,0.001020353357869624,0.9994337409379251,43,2326,cellular catabolic process,BP
GO:0001558,0.0010294217223483404,0.9996760051256172,13,414,regulation of cell growth,BP
GO:0010470,0.0010479247058502675,0.9999158068209422,4,42,regulation of gastrulation,BP
GO:0032386,0.0010622799301982845,0.9996644286133364,13,422,regulation of intracellular transport,BP
GO:0030501,0.0010656370054876057,0.9999144111344406,4,39,positive regulation of bone mineralization,BP
GO:0044440,0.001066085536850486,0.99962967916712,15,524,endosomal part,CC
GO:0048762,0.001068741645321831,0.9997485630921488,9,219,mesenchymal cell differentiation,BP
GO:0071498,0.0010762851450673299,0.999953037930891,3,21,cellular response to fluid shear stress,BP
GO:0045429,0.0010765881032346273,0.9999128704385516,4,42,positive regulation of nitric oxide biosynthetic process,BP
GO:0070665,0.0010772043042449582,0.9998035193477761,7,139,positive regulation of leukocyte proliferation,BP
GO:0071360,0.0010794234650341446,0.9999540955103735,3,17,cellular response to exogenous dsRNA,BP
GO:1990837,0.0010800953465016413,0.9995364029671103,22,887,sequence-specific double-stranded DNA binding,MF
GO:0038084,0.0010806372842148703,0.9999122046592765,4,44,vascular endothelial growth factor signaling pathway,BP
GO:0006066,0.0010819809442670636,0.9996766722565994,12,364,alcohol metabolic process,BP
GO:1901214,0.001090974001010228,0.9996945678366634,11,317,regulation of neuron death,BP
GO:0098791,0.0010911358087322908,0.9995416834410411,21,859,Golgi subcompartment,CC
GO:0009581,0.0011004929661689996,0.9997987237791444,7,134,detection of external stimulus,BP
GO:0035690,0.0011224266743426305,0.9996630890421827,12,369,cellular response to drug,BP
GO:0039529,0.0011323494798917853,0.9999499890472828,3,20,RIG-I signaling pathway,BP
GO:2001237,0.0011481632735933734,0.9998237924661089,6,103,negative regulation of extrinsic apoptotic signaling pathway,BP
GO:0003924,0.0011630345990148207,0.9996717455110606,11,321,GTPase activity,MF
GO:0045580,0.001167625615919063,0.9997840478677564,7,139,regulation of T cell differentiation,BP
GO:0001938,0.001169844316372394,0.9998193543923098,6,112,positive regulation of endothelial cell proliferation,BP
GO:0010594,0.0011704145176432462,0.9997494674123353,8,230,regulation of endothelial cell migration,BP
GO:0050891,0.0011750007384367948,0.9998592342917261,5,68,multicellular organismal water homeostasis,BP
GO:0032414,0.0011793734625829826,0.999818001219926,6,104,positive regulation of ion transmembrane transporter activity,BP
GO:1904407,0.0011858837134055453,0.9999013356484645,4,43,positive regulation of nitric oxide metabolic process,BP
GO:0046631,0.001190874899550813,0.9997790379453204,7,138,alpha-beta T cell activation,BP
GO:2001259,0.0011920844813663445,0.9998565452233862,5,70,positive regulation of cation channel activity,BP
GO:0031580,0.001203241973049496,0.9999866090068174,2,5,membrane raft distribution,BP
GO:0032993,0.0012041746897242978,0.9997417099716123,8,201,protein-DNA complex,CC
GO:0140096,0.0012106005110766337,0.9993320820813092,41,2161,"catalytic activity, acting on a protein",MF
GO:0002710,0.001212502966952187,0.9999454961784816,3,19,negative regulation of T cell mediated immunity,BP
GO:0072171,0.0012128201895019277,0.9998538560923511,5,66,mesonephric tubule morphogenesis,BP
GO:0097028,0.0012142205975765044,0.9998984768347545,4,42,dendritic cell differentiation,BP
GO:0006956,0.0012169438986851687,0.999852699775081,5,72,complement activation,BP
GO:0034705,0.001225976958935058,0.9998098743053978,6,96,potassium channel complex,CC
GO:0060406,0.001230782772624079,0.9999861439619215,2,5,positive regulation of penile erection,BP
GO:0051121,0.0012313333406436743,0.9999861346104417,2,5,hepoxilin metabolic process,BP
GO:0051122,0.0012313333406436743,0.9999861346104417,2,5,hepoxilin biosynthetic process,BP
GO:0051427,0.0012357647033351493,0.9997342950822643,8,185,hormone receptor binding,MF
GO:0014900,0.0012406487634814922,0.9999859760627141,2,5,muscle hyperplasia,BP
GO:0010008,0.0012414242288756447,0.9995807986548524,14,477,endosome membrane,CC
GO:0007189,0.0012444984717548224,0.9997672385421597,7,140,adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP
GO:0009582,0.0012545370389310726,0.9997651649539276,7,137,detection of abiotic stimulus,BP
GO:0005534,0.0012557325257500143,0.999985718045492,2,5,galactose binding,MF
GO:0008610,0.0012772527026655971,0.9994979042426353,18,707,lipid biosynthetic process,BP
GO:0098644,0.0012836874226283608,0.9999411355963246,3,19,complex of collagen trimers,CC
GO:0060374,0.001293787776833586,0.9999850600387445,2,5,mast cell differentiation,BP
GO:0032847,0.0012959210529195082,0.9999850228558993,2,5,regulation of cellular pH reduction,BP
GO:0002920,0.0013065124616273107,0.9998392165285335,5,73,regulation of humoral immune response,BP
GO:0010467,0.001307514283124011,0.9991221810864774,90,6419,gene expression,BP
GO:0044306,0.0013117378903430015,0.999752462629202,7,139,neuron projection terminus,CC
GO:0071284,0.0013183543942831637,0.9999846299515541,2,5,cellular response to lead ion,BP
GO:0031345,0.0013214043428678508,0.999712790885381,8,188,negative regulation of cell projection organization,BP
GO:0030175,0.0013248648382462756,0.9997908002659993,6,105,filopodium,CC
GO:0006631,0.0013310678845112759,0.9995922226108965,12,383,fatty acid metabolic process,BP
GO:1904064,0.0013371168793597729,0.9997466104347348,7,144,positive regulation of cation transmembrane transport,BP
GO:0022614,0.0013465268034257123,0.999984131665838,2,5,membrane to membrane docking,BP
GO:0009165,0.0013477700100818486,0.9995864873884657,12,384,nucleotide biosynthetic process,BP
GO:0016247,0.0013548469331972318,0.9997427521263627,7,142,channel regulator activity,MF
GO:0007369,0.0013599247855195363,0.9997031806436031,8,185,gastrulation,BP
GO:0032612,0.0013634385694270262,0.9997829738849526,6,114,interleukin-1 production,BP
GO:0016049,0.0013722223336525585,0.9995316493507527,14,482,cell growth,BP
GO:0043546,0.0013745156735225866,0.9999821951708932,2,6,molybdopterin cofactor binding,MF
GO:0072079,0.0013749059871275612,0.9999358705408892,3,18,nephron tubule formation,BP
GO:0060078,0.0013824920277940534,0.9997366278200642,7,141,regulation of postsynaptic membrane potential,BP
GO:1901606,0.0013853906651497686,0.9997791988321199,6,107,alpha-amino acid catabolic process,BP
GO:0032682,0.0013882789632087334,0.9999337998906552,3,21,negative regulation of chemokine production,BP
GO:0097305,0.0014006263330289014,0.9996570441183419,9,234,response to alcohol,BP
GO:0004930,0.001411903963624941,0.9993945686402301,21,838,G protein-coupled receptor activity,MF
GO:0071798,0.0014126594247908868,0.9999829409840642,2,5,response to prostaglandin D,BP
GO:0071799,0.0014126594247908868,0.9999829409840642,2,5,cellular response to prostaglandin D stimulus,BP
GO:0006897,0.0014207308864880005,0.9994360857180982,18,716,endocytosis,BP
GO:0016829,0.0014245761135778913,0.9996866903891541,8,188,lyase activity,MF
GO:0033003,0.00142921116691323,0.9998749076036113,4,43,regulation of mast cell activation,BP
GO:0072006,0.0014320142183242058,0.9997254724094359,7,142,nephron development,BP
GO:0072162,0.0014352260194991449,0.9999825280370649,2,5,metanephric mesenchymal cell differentiation,BP
GO:0050728,0.001436009921413078,0.9997234857776619,7,169,negative regulation of inflammatory response,BP
GO:0003085,0.0014370653699874612,0.9999310243579127,3,20,negative regulation of systemic arterial blood pressure,BP
GO:0071300,0.0014516446430235834,0.9998174769683928,5,69,cellular response to retinoic acid,BP
GO:1901293,0.0014558939217560467,0.9995491812783542,12,388,nucleoside phosphate biosynthetic process,BP
GO:0070011,0.0014596056472658896,0.9994561303297108,16,594,"peptidase activity, acting on L-amino acid peptides",MF
GO:0097190,0.0014604616701658951,0.9994556949748152,16,604,apoptotic signaling pathway,BP
GO:1901566,0.0014609456878898227,0.9992188290413719,36,1949,organonitrogen compound biosynthetic process,BP
GO:0060231,0.0014709286920535712,0.999929260649155,3,19,mesenchymal to epithelial transition,BP
GO:0072179,0.0014789975857567212,0.9999817175574607,2,5,nephric duct formation,BP
GO:0010517,0.0014794254140152554,0.9998130703409536,5,70,regulation of phospholipase activity,BP
GO:0048660,0.0014817817213577944,0.9997130772969857,7,170,regulation of smooth muscle cell proliferation,BP
GO:0032418,0.0014915178664424032,0.9998106693837657,5,75,lysosome localization,BP
GO:0007200,0.0015108372637819168,0.999755601181209,6,100,phospholipase C-activating G protein-coupled receptor signaling pathway,BP
GO:0032958,0.00151889144585345,0.9998650312166069,4,42,inositol phosphate biosynthetic process,BP
GO:0045723,0.001520658122503489,0.9999247657095995,3,22,positive regulation of fatty acid biosynthetic process,BP
GO:0045807,0.0015220184276450366,0.9997046273600066,7,152,positive regulation of endocytosis,BP
GO:0072087,0.0015261925433061034,0.9999256488345074,3,19,renal vesicle development,BP
GO:0007620,0.0015394630088769467,0.9999243076273794,3,20,copulation,BP
GO:0006144,0.0015459602396449847,0.9999234532770922,3,21,purine nucleobase metabolic process,BP
GO:0019233,0.001550134023719387,0.9997475904123531,6,105,sensory perception of pain,BP
GO:0019674,0.0015586335537401844,0.9998000646324102,5,76,NAD metabolic process,BP
GO:0009914,0.0015627131847242744,0.999542319478275,11,324,hormone transport,BP
GO:0010595,0.001567666299178407,0.9997427684458936,6,128,positive regulation of endothelial cell migration,BP
GO:0015085,0.0015714845292740028,0.9996939837958214,7,139,calcium ion transmembrane transporter activity,MF
GO:0035546,0.0015748131032486837,0.9999799004128416,2,5,interferon-beta secretion,BP
GO:0035547,0.0015748131032486837,0.9999799004128416,2,5,regulation of interferon-beta secretion,BP
GO:0072524,0.001587654111425463,0.9996445545430575,8,195,pyridine-containing compound metabolic process,BP
GO:0097237,0.0016032988874149369,0.9995993372009714,9,246,cellular response to toxic substance,BP
GO:0098533,0.0016148490106754323,0.9999188117575706,3,21,ATPase dependent transmembrane transport complex,CC
GO:0030135,0.0016199830297054837,0.9995572628347282,10,286,coated vesicle,CC
GO:0035743,0.0016274471807878426,0.9999179552109985,3,21,"CD4-positive, alpha-beta T cell cytokine production",BP
GO:0032413,0.0016284614467955833,0.9997887146742557,5,79,negative regulation of ion transmembrane transporter activity,BP
GO:0061337,0.0016318409863891972,0.9996797464006255,7,146,cardiac conduction,BP
GO:0046982,0.0016323339221969426,0.9994322267241527,14,504,protein heterodimerization activity,MF
GO:1901881,0.0016365477838905164,0.9999177910681791,3,20,positive regulation of protein depolymerization,BP
GO:0045446,0.0016371581859922046,0.9997299619614837,6,113,endothelial cell differentiation,BP
GO:0060353,0.0016429899418598753,0.9999753943599984,2,7,regulation of cell adhesion molecule production,BP
GO:1903524,0.0016431445774986427,0.9997870172895852,5,73,positive regulation of blood circulation,BP
GO:0051146,0.001646881156437416,0.9995487521417322,10,293,striated muscle cell differentiation,BP
GO:0019933,0.0016497448461268334,0.9996286359653546,8,189,cAMP-mediated signaling,BP
GO:0008277,0.0016526454702552112,0.9996746874180279,7,151,regulation of G protein-coupled receptor signaling pathway,BP
GO:0050731,0.0016548022851760797,0.9996272010636649,8,192,positive regulation of peptidyl-tyrosine phosphorylation,BP
GO:0070734,0.0016574932758640275,0.9999159028869044,3,21,histone H3-K27 methylation,BP
GO:0014047,0.0016593524580047255,0.9998485209317295,4,44,glutamate secretion,BP
GO:0030104,0.0016646873355154034,0.999783469055915,5,74,water homeostasis,BP
GO:0008273,0.0016758540373168307,0.9999779217579661,2,5,"calcium, potassium:sodium antiporter activity",MF
GO:0023019,0.0016819655279345768,0.9999146945333384,3,20,signal transduction involved in regulation of gene expression,BP
GO:0072111,0.001689274782051611,0.9999137175948997,3,21,cell proliferation involved in kidney development,BP
GO:1904469,0.0016915025367437591,0.9999135638628598,3,21,positive regulation of tumor necrosis factor secretion,BP
GO:0031669,0.001693514513293115,0.99957371290105,9,236,cellular response to nutrient levels,BP
GO:0070482,0.0016935575290052958,0.9994660248600321,12,394,response to oxygen levels,BP
GO:0044853,0.0017012069900803077,0.9997174898713933,6,110,plasma membrane raft,CC
GO:0031497,0.0017019316144301483,0.9996626894800935,7,163,chromatin assembly,BP
GO:0001618,0.0017035412783417997,0.9997772500006509,5,74,virus receptor activity,MF
GO:0104005,0.0017035412783417997,0.9997772500006509,5,74,hijacked molecular function,MF
GO:0060485,0.0017057659889179125,0.9995307700523661,10,278,mesenchyme development,BP
GO:0002832,0.0017066425028909548,0.9998424137599694,4,47,negative regulation of response to biotic stimulus,BP
GO:0002029,0.001717986424039326,0.9999117307745128,3,21,desensitization of G protein-coupled receptor signaling pathway,BP
GO:0022401,0.001717986424039326,0.9999117307745128,3,21,negative adaptation of signaling pathway,BP
GO:0032411,0.0017327651921930866,0.9997110562443131,6,112,positive regulation of transporter activity,BP
GO:0051665,0.0017393651790142562,0.9999745998146917,2,6,membrane raft localization,BP
GO:0001822,0.001741451734059874,0.9995196135950128,10,278,kidney development,BP
GO:0002688,0.0017440032882883876,0.99970873835787,6,113,regulation of leukocyte chemotaxis,BP
GO:0002438,0.001751208336324473,0.9999089653020646,3,22,acute inflammatory response to antigenic stimulus,BP
GO:0006979,0.001755192040212591,0.9994132128114679,13,452,response to oxidative stress,BP
GO:1901654,0.0017593438570657027,0.9995997457368042,8,193,response to ketone,BP
GO:0031099,0.0017608859098903733,0.9995991810700492,8,197,regeneration,BP
GO:2000667,0.001792666000140015,0.9999734155043113,2,6,positive regulation of interleukin-13 secretion,BP
GO:0002820,0.001793731006152025,0.9998325110995651,4,45,negative regulation of adaptive immune response,BP
GO:0032680,0.001799263766814255,0.999640054787263,7,160,regulation of tumor necrosis factor production,BP
GO:0046173,0.0018033675122408172,0.9997611208740711,5,74,polyol biosynthetic process,BP
GO:0005506,0.001807832858044276,0.999638506855513,7,151,iron ion binding,MF
GO:0010863,0.0018111958902496505,0.9998308843559145,4,43,positive regulation of phospholipase C activity,BP
GO:0048167,0.0018192174838049457,0.9995841362291882,8,188,regulation of synaptic plasticity,BP
GO:0030278,0.001849026128967765,0.9995756839932136,8,201,regulation of ossification,BP
GO:0019800,0.0018589016733361727,0.9999719184375593,2,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP
GO:0008134,0.0018630284743307722,0.9992647446912398,17,660,transcription factor binding,MF
GO:1903409,0.0018712383480978636,0.9996825304214564,6,121,reactive oxygen species biosynthetic process,BP
GO:0035584,0.0018754876610429367,0.9999001292334814,3,22,calcium-mediated signaling using intracellular calcium source,BP
GO:0030881,0.0018901242444743932,0.9999712031243412,2,6,beta-2-microglobulin binding,MF
GO:0010638,0.0018907122268915367,0.9992771527756631,16,619,positive regulation of organelle organization,BP
GO:0003724,0.0019047144796274272,0.9997441430447745,5,77,RNA helicase activity,MF
GO:0048609,0.0019123652825907144,0.9991780535286612,20,838,multicellular organismal reproductive process,BP
GO:0072009,0.0019140262845074463,0.9996747592395858,6,109,nephron epithelium development,BP
GO:0009713,0.001918679707345508,0.9998975188187005,3,21,catechol-containing compound biosynthetic process,BP
GO:0042423,0.001918679707345508,0.9998975188187005,3,21,catecholamine biosynthetic process,BP
GO:0045664,0.0019364755153770397,0.9992329838838371,17,657,regulation of neuron differentiation,BP
GO:0022843,0.0019367497571640192,0.9996085891724205,7,142,voltage-gated cation channel activity,MF
GO:0014821,0.0019373047461717751,0.9998961719412294,3,21,phasic smooth muscle contraction,BP
GO:0002009,0.0019376771561497592,0.9992847005333139,15,538,morphogenesis of an epithelium,BP
GO:0099056,0.0019436361601344906,0.9997382445112717,5,73,integral component of presynaptic membrane,CC
GO:0030218,0.0019439344203207635,0.9996682387529882,6,114,erythrocyte differentiation,BP
GO:0009190,0.001947658353092985,0.9998949005350928,3,22,cyclic nucleotide biosynthetic process,BP
GO:0052652,0.001947658353092985,0.9998949005350928,3,22,cyclic purine nucleotide metabolic process,BP
GO:0032813,0.0019660555520309314,0.9998115134544147,4,46,tumor necrosis factor receptor superfamily binding,MF
GO:0023058,0.00199811160907523,0.99989120384398,3,22,adaptation of signaling pathway,BP
GO:1903555,0.0020010550380803664,0.9995919835014648,7,163,regulation of tumor necrosis factor superfamily cytokine production,BP
GO:0042113,0.0020069895490485356,0.9994819200920934,9,242,B cell activation,BP
GO:0072078,0.0020108827096789357,0.9997269295982185,5,74,nephron tubule morphogenesis,BP
GO:0070613,0.0020156073977757863,0.9996532074837872,6,118,regulation of protein processing,BP
GO:0032640,0.002015747610579772,0.9995884583091699,7,163,tumor necrosis factor production,BP
GO:0001503,0.002016709112046114,0.9993507192981131,12,396,ossification,BP
GO:0033554,0.0020244764097473306,0.9988771757675461,38,2062,cellular response to stress,BP
GO:0030282,0.0020350689620217723,0.9996496086993466,6,113,bone mineralization,BP
GO:0030667,0.002040692175363279,0.999424311931426,10,296,secretory granule membrane,CC
GO:0031965,0.002067847702718055,0.9994156019014335,10,296,nuclear membrane,CC
GO:0070169,0.0020841161807559536,0.9997967298425902,4,47,positive regulation of biomineral tissue development,BP
GO:0042626,0.0020861930953988204,0.9996389474677181,6,114,"ATPase activity, coupled to transmembrane movement of substances",MF
GO:0043492,0.0020861930953988204,0.9996389474677181,6,114,"ATPase activity, coupled to movement of substances",MF
GO:0043330,0.0020874099521009677,0.9997965615014752,4,46,response to exogenous dsRNA,BP
GO:0015740,0.0020901302718760177,0.9998838556665772,3,23,C4-dicarboxylate transport,BP
GO:0071608,0.0021214196793135666,0.9999657173209161,2,6,macrophage inflammatory protein-1 alpha production,BP
GO:0071640,0.0021214196793135666,0.9999657173209161,2,6,regulation of macrophage inflammatory protein 1 alpha production,BP
GO:1903672,0.0021248959191042193,0.9997886596419832,4,64,positive regulation of sprouting angiogenesis,BP
GO:0042304,0.0021250064334908626,0.999789990505648,4,55,regulation of fatty acid biosynthetic process,BP
GO:0007157,0.0021352858368520744,0.9997903463884865,4,47,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP
GO:0034767,0.0021407853996588053,0.9995586894797409,7,156,positive regulation of ion transmembrane transport,BP
GO:0031396,0.0021481850893299544,0.9994949744875086,8,204,regulation of protein ubiquitination,BP
GO:0030216,0.0021566772253186284,0.9993867681197681,10,304,keratinocyte differentiation,BP
GO:0031849,0.0021581476337885165,0.9999648166358899,2,6,olfactory receptor binding,MF
GO:1900274,0.002168565874661779,0.9997866891850562,4,45,regulation of phospholipase C activity,BP
GO:2001233,0.0021733716975984806,0.9992937485647629,12,407,regulation of apoptotic signaling pathway,BP
GO:0008233,0.002200774784157693,0.999145889222145,16,618,peptidase activity,MF
GO:0020005,0.002205559263937576,0.9999636422473904,2,6,symbiont-containing vacuole membrane,CC
GO:0071621,0.002215362703362198,0.9996112904107034,6,122,granulocyte chemotaxis,BP
GO:0099106,0.002216259282179483,0.9996116209029096,6,116,ion channel regulator activity,MF
GO:0006357,0.0022168603704817713,0.9986781502911167,48,2679,regulation of transcription by RNA polymerase II,BP
GO:0071359,0.0022191645734307157,0.9998746196305084,3,22,cellular response to dsRNA,BP
GO:1903317,0.0022262879706351087,0.9996091596257103,6,120,regulation of protein maturation,BP
GO:1903510,0.002228319223194267,0.9996093687578687,6,113,mucopolysaccharide metabolic process,BP
GO:0006566,0.0022528540413845077,0.9999603684346698,2,7,threonine metabolic process,BP
GO:1904035,0.0022558405714728615,0.999683444888446,5,89,regulation of epithelial cell apoptotic process,BP
GO:0051291,0.002258213164384003,0.9996018580264346,6,127,protein heterooligomerization,BP
GO:0071260,0.002281187838991869,0.9996803614985087,5,79,cellular response to mechanical stimulus,BP
GO:0003012,0.0022883368055864463,0.9992113617894827,13,466,muscle system process,BP
GO:0072604,0.002306624711777937,0.9997684004140156,4,48,interleukin-6 secretion,BP
GO:0006898,0.0023083117887830232,0.9993911918629343,9,257,receptor-mediated endocytosis,BP
GO:0034364,0.00232007488100031,0.9998647411492068,3,26,high-density lipoprotein particle,CC
GO:0001937,0.0023203821645577435,0.9997620305171249,4,77,negative regulation of endothelial cell proliferation,BP
GO:0032504,0.002328800859711439,0.9989818442131705,20,853,multicellular organism reproduction,BP
GO:0072170,0.0023370119120755214,0.9998649259787256,3,23,metanephric tubule development,BP
GO:0009597,0.002353219422064809,0.9999599015490719,2,6,detection of virus,BP
GO:0042461,0.002368525396992786,0.9997607139809153,4,47,photoreceptor cell development,BP
GO:2000553,0.0023735853454250957,0.9999571159426284,2,7,positive regulation of T-helper 2 cell cytokine production,BP
GO:0007626,0.0023738512749237805,0.9994331771802472,8,199,locomotory behavior,BP
GO:1905114,0.002376480867718483,0.9990705399790084,16,624,cell surface receptor signaling pathway involved in cell-cell signaling,BP
GO:0032727,0.0023827776869229807,0.9998619548415129,3,22,positive regulation of interferon-alpha production,BP
GO:0097696,0.002394110076286189,0.9994958824275438,7,167,STAT cascade,BP
GO:1903727,0.002396882639544313,0.9997567788501257,4,48,positive regulation of phospholipid metabolic process,BP
GO:0046135,0.0023983788137538387,0.9998595345976732,3,24,pyrimidine nucleoside catabolic process,BP
GO:0071706,0.002401702041324733,0.9994939384516632,7,168,tumor necrosis factor superfamily cytokine production,BP
GO:0051205,0.0024261930712663284,0.9997527111499631,4,49,protein insertion into membrane,BP
GO:0003014,0.0024312331287239977,0.9995659271095853,6,117,renal system process,BP
GO:0000978,0.002448051506379385,0.9990740748804093,15,542,RNA polymerase II proximal promoter sequence-specific DNA binding,MF
GO:0009117,0.0024573420796431137,0.999003688137407,17,706,nucleotide metabolic process,BP
GO:0009913,0.0024759898287279015,0.9992302230781464,11,357,epidermal cell differentiation,BP
GO:0045840,0.002506127092329461,0.9997412653571802,4,53,positive regulation of mitotic nuclear division,BP
GO:0061333,0.0025080722215260216,0.9996409949418509,5,78,renal tubule morphogenesis,BP
GO:1903306,0.002514477309724394,0.9998502566064226,3,24,negative regulation of regulated secretory pathway,BP
GO:0033081,0.0025183239706223944,0.9998499465245299,3,24,regulation of T cell differentiation in thymus,BP
GO:0009059,0.0025212866950009155,0.9983071705094925,79,5089,macromolecule biosynthetic process,BP
GO:0050687,0.002528701853555566,0.9998491091092544,3,24,negative regulation of defense response to virus,BP
GO:0043565,0.0025463387223092354,0.9987645142655266,25,1135,sequence-specific DNA binding,MF
GO:0060218,0.002552789196266693,0.9996322982893034,5,83,hematopoietic stem cell differentiation,BP
GO:0043027,0.002557828495481447,0.9998461819618902,3,25,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF
GO:0072001,0.0025594401121253377,0.9992553813230975,10,293,renal system development,BP
GO:0019439,0.002568683804844591,0.9989540019596019,17,714,aromatic compound catabolic process,BP
GO:0070997,0.002579511864577622,0.9991939468400626,11,352,neuron death,BP
GO:0051262,0.0025832025009827446,0.9994483519805212,7,172,protein tetramerization,BP
GO:0032648,0.002588659159831695,0.9997316780745319,4,48,regulation of interferon-beta production,BP
GO:0032410,0.002595768166227614,0.999623672996127,5,90,negative regulation of transporter activity,BP
GO:0046643,0.0026285110890063535,0.9999499671071906,2,7,regulation of gamma-delta T cell activation,BP
GO:0034101,0.0026438600128677937,0.999519470944971,6,122,erythrocyte homeostasis,BP
GO:0002719,0.002644387471593136,0.9998390951620166,3,25,negative regulation of cytokine production involved in immune response,BP
GO:0060405,0.002678059898205702,0.9999485345009287,2,7,regulation of penile erection,BP
GO:0006855,0.002679059289253995,0.9996099553886091,5,82,drug transmembrane transport,BP
GO:0006753,0.0027096918219469473,0.998890889315039,17,713,nucleoside phosphate metabolic process,BP
GO:0050730,0.0027127231308240046,0.9992672942376668,9,256,regulation of peptidyl-tyrosine phosphorylation,BP
GO:0061436,0.002746289748173068,0.9998319558919669,3,23,establishment of skin barrier,BP
GO:0060753,0.002752271563899719,0.9999463631574129,2,7,regulation of mast cell chemotaxis,BP
GO:0032757,0.0027731923170339337,0.999706708101383,4,49,positive regulation of interleukin-8 production,BP
GO:0043654,0.0027752209877773843,0.9999456855079565,2,7,recognition of apoptotic cell,BP
GO:0015405,0.0027822190042140105,0.9994891354714809,6,122,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF
GO:0002729,0.0027902197013466618,0.9999452410599435,2,7,positive regulation of natural killer cell cytokine production,BP
GO:1903428,0.002816912299874547,0.9996991138425482,4,55,positive regulation of reactive oxygen species biosynthetic process,BP
GO:0005223,0.002835551347621642,0.9999438902807979,2,7,intracellular cGMP-activated cation channel activity,MF
GO:0034707,0.0028426905853412353,0.9996969781971148,4,50,chloride channel complex,CC
GO:0001915,0.002846916946403108,0.9999435498534204,2,7,negative regulation of T cell mediated cytotoxicity,BP
GO:0002931,0.0028596311074806317,0.9996946702181988,4,50,response to ischemia,BP
GO:0071377,0.0028896050054410235,0.9998179515386796,3,26,cellular response to glucagon stimulus,BP
GO:0002507,0.0028961606846022434,0.9998180113680931,3,25,tolerance induction,BP
GO:0035926,0.0029099486096716633,0.9999393977419836,2,8,chemokine (C-C motif) ligand 2 secretion,BP
GO:0042058,0.002917385839213066,0.999566120154188,5,86,regulation of epidermal growth factor receptor signaling pathway,BP
GO:0019369,0.0029438075598435015,0.9996828321508917,4,51,arachidonic acid metabolic process,BP
GO:0016740,0.0029452154108243604,0.9982923836108343,41,2266,transferase activity,MF
GO:0031622,0.002946292012998396,0.9999405435499022,2,7,positive regulation of fever generation,BP
GO:1904063,0.002946633923379157,0.9995598229223827,5,92,negative regulation of cation transmembrane transport,BP
GO:0010460,0.002949041207417379,0.9998128621684581,3,26,positive regulation of heart rate,BP
GO:0030203,0.002980906939253735,0.9993478395356978,7,161,glycosaminoglycan metabolic process,BP
GO:0042421,0.003006475711428944,0.9999386971191342,2,7,norepinephrine biosynthetic process,BP
GO:0038085,0.003007772755501925,0.9999386571139238,2,7,vascular endothelial growth factor binding,MF
GO:0015399,0.0030127007145630894,0.9994376797478856,6,124,primary active transmembrane transporter activity,MF
GO:0032608,0.0030183817946117207,0.9996728555879819,4,50,interferon-beta production,BP
GO:0051216,0.00303387764093134,0.9992457739344122,8,207,cartilage development,BP
GO:0014732,0.0030370046284248966,0.9999377531429557,2,7,skeletal muscle atrophy,BP
GO:2000272,0.0030533795395755246,0.9996670582000594,4,53,negative regulation of signaling receptor activity,BP
GO:0043679,0.0030631772665297963,0.9994268242009101,6,120,axon terminus,CC
GO:0020003,0.003063719910206606,0.9999369230519576,2,7,symbiont-containing vacuole,CC
GO:0072523,0.0030774577233233457,0.9996640053869521,4,52,purine-containing compound catabolic process,BP
GO:0031424,0.0030883159071298564,0.9992290481915633,8,223,keratinization,BP
GO:0006909,0.0030914934525608177,0.9991480965465568,9,266,phagocytosis,BP
GO:0002732,0.003105041006369115,0.9999356317516314,2,7,positive regulation of dendritic cell cytokine production,BP
GO:0043523,0.003121980975058066,0.9992198674826956,8,213,regulation of neuron apoptotic process,BP
GO:0045214,0.003140481533185135,0.9996548759369341,4,53,sarcomere organization,BP
GO:1990776,0.003148080199000901,0.9997943206946877,3,28,response to angiotensin,BP
GO:0072202,0.003158411174185963,0.9997953373500664,3,25,cell differentiation involved in metanephros development,BP
GO:0000987,0.00315942070812627,0.9987722554455367,15,557,proximal promoter sequence-specific DNA binding,MF
GO:0046717,0.003171848207932762,0.9994018127746406,6,124,acid secretion,BP
GO:0005021,0.003193893239861183,0.9999328249564239,2,7,vascular endothelial growth factor-activated receptor activity,MF
GO:0031995,0.0031979915570562773,0.9999300997018932,2,8,insulin-like growth factor II binding,MF
GO:0070098,0.0032036189050345092,0.9995129249231975,5,87,chemokine-mediated signaling pathway,BP
GO:1901137,0.0032504786462146497,0.9986069657180854,18,770,carbohydrate derivative biosynthetic process,BP
GO:0097066,0.0032703124267389307,0.9997847219348994,3,26,response to thyroid hormone,BP
GO:0009063,0.0032803885595421175,0.9993768876120616,6,126,cellular amino acid catabolic process,BP
GO:0060352,0.00328069808127984,0.9999252848368773,2,9,cell adhesion molecule production,BP
GO:0051186,0.0033350976920667793,0.9986956525997496,15,601,cofactor metabolic process,BP
GO:0006366,0.0033436597786089704,0.997952319247301,49,2815,transcription by RNA polymerase II,BP
GO:0002230,0.0033497773896219514,0.9997776022630892,3,26,positive regulation of defense response to virus by host,BP
GO:0001773,0.0033614863023187984,0.9997752045183687,3,28,myeloid dendritic cell activation,BP
GO:0005328,0.0033761338906998875,0.9997752272674175,3,26,neurotransmitter:sodium symporter activity,MF
GO:1902932,0.0033820015964434384,0.9997733431780733,3,28,positive regulation of alcohol biosynthetic process,BP
GO:1903959,0.0033865891633369813,0.9997742832772278,3,26,regulation of anion transmembrane transport,BP
GO:0050920,0.0034120476175307293,0.9991347532191422,8,216,regulation of chemotaxis,BP
GO:0051603,0.0034189896516022794,0.9985685204662882,17,714,proteolysis involved in cellular protein catabolic process,BP
GO:0014068,0.0034390204363810425,0.9994684490768428,5,87,positive regulation of phosphatidylinositol 3-kinase signaling,BP
GO:0018149,0.00343961846767422,0.9996101960947665,4,60,peptide cross-linking,BP
GO:0030901,0.003456480362422733,0.999464548649927,5,90,midbrain development,BP
GO:0031701,0.0034768288282231263,0.9999206761207499,2,8,angiotensin receptor binding,MF
GO:0007176,0.0035184191948708166,0.9997615494107774,3,27,regulation of epidermal growth factor-activated receptor activity,BP
GO:0035456,0.0035283664945313957,0.9997599459423162,3,28,response to interferon-beta,BP
